ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000795.1|S-layer_1 # 3 # 86 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.512	BGC0000795.1|S-layer_1 	3	86	+	Loose	350	19.631	AAC(2')-Ie	63.64	3002527	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(2')	GCTCATCGGTTGGGTCGGCCAGAAGAAAAAACCGCTTTGGAAACGGCGCGCAGAATCAAGCAGATGACAACAGGAAAGCAATGA	AHRLGRPEEKTALETARRIKQMTTGKQ	MDTHHVHTARLVHTADLDGETLRRLQQMVTDAFAGDFDETDWEHALGGMHALIWRHGTIIAHAAVVQRRLFYHGNALRCGYLEGVAVRKDCRGRGLVHALLDAIEQVIRGAYQFGALSSSDRARRVYMSRGWLPWLGPTSVLAPTGVIRTPDDDGSVFVLPVGINPDTSSGLMCDWRAGNVW	14.84	gnl|BL_ORD_ID|2421|hsp_num:0	2832			57	90	dibekacin; netilmicin; tobramycin; 6'-N-ethylnetilmicin; gentamicin
BGC0000795.1|S-layer_2 # 83 # 175 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=6bp;gc_cont=0.495	BGC0000795.1|S-layer_2 	83	175	+	Loose	800	20.7866	mel	47.06	3000616	protein homolog model	n/a	n/a	macrolide antibiotic; streptogramin antibiotic	antibiotic target protection	msr-type ABC-F protein	ATGAGTGAAAGAGACGAGTGCTTGGCGCTCGTCTTTTTATTAGGCTTTTTTCCACCAGCTTTTTACCGCCCACCGCAACGGCATGCTGCTTGA	MSERDECLALVFLLGFFPPAFYRPPQRHAA	MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLLGFLPYAVFGPAIGVLVDRHDRKKIMIGADLIIAAAGSVLTIVAFYMELPVWMVMIVLFIRSIGTAFHTPALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWELNAIIAIDVLGAVIASITVAIVRIPKLGDRVQSLDPNFIREMQEGMAVLRQNKGLFALLLVGTLYMFVYMPINALFPLISMDYFNGTPVHISITEISFASGMLIGGLLLGLFGNYQKRILLITASIFMMGISLTISGLLPQSGFFIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMPIGLILSALFADRIGVNHWFLLSGTLIICIAIVCPMINEIRKLDLK	7.41	gnl|BL_ORD_ID|1130|hsp_num:0	1231			135	186	erythromycin; telithromycin
BGC0000795.1|S-layer_3 # 390 # 1079 # 1 # ID=1_3;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.478	BGC0000795.1|S-layer_3 	390	1079	+	Loose	750	27.7202	tet(53)	28.0	3004589	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	TTGGTCACGGTGTGTGGGTTACTATCTGGTGCATGGTTGCCCGGAGCGCCGGTTGTTTTGGCACAGGAAATCAAAACAGGAGCGCCGGCTGTTGTCAGCATCCAGACCGAAAACGGAATGGACGCGAAAGCCAAACAGCCGACTGACGTAAGATGGGTGATTCGTTTTAATACGCCAATCGAACGCTATACGGTCGATGATAGCGCTTTGTTCGTAAAGGATGAATCCGGTAATAAAGTATCTGTCACGCTTGTGTTTGGCGATAAAGATCAAACCATTACGGTCAAACCGCCCACAAACGGATATGGATCGGGACAAACATACTTTTTGTGCGTAAACGATAGTATTTACGCCAAGTCAGGCAAGAAACTCAGCGCCTCGGTCACACAGAAATTCCAAATTCAAAATGAAATTGTAAGCATTCAGGGAGATAAAGACCACACCTTCTTCATCGGTAAAAAAGAAGTTTGGAGAAGCGGAAAGGAAAACTTCCTACCGACAACAGAACAAGGCAAAAACCTTGCGACCCCGCAGCTTTTTAAAGAGCTGAGCGATATAAAAACCATTGTGAATGGCAAGGAGCATTTCCTGGCGCTGACCAACGACGGAACGGTCTGGGCCTGGGGCACAAACAAATCGGCGAACTGGGCCATGGTACGAACCAGTCACGCAATACGCCGGTACAGGTAA	MVTVCGLLSGAWLPGAPVVLAQEIKTGAPAVVSIQTENGMDAKAKQPTDVRWVIRFNTPIERYTVDDSALFVKDESGNKVSVTLVFGDKDQTITVKPPTNGYGSGQTYFLCVNDSIYAKSGKKLSASVTQKFQIQNEIVSIQGDKDHTFFIGKKEVWRSGKENFLPTTEQGKNLATPQLFKELSDIKTIVNGKEHFLALTNDGTVWAWGTNKSANWAMVRTSHAIRRYR	MSTINKILVIGAGIAGPAVCYWLRRFGFSPVLIEKFANIRKEGQALDFRGVAIDIVKGMNIYEKMCNMHKQLEVGRYVDTEGNTLHEERGERFCFRQGEDVEIARGDFAEILTGAIEGIPCHFNQVIDSIKQSDDDVKVQFNDGRVEHYDLVIGADGIYSTTRGMVFDKDEYKLVNLGVCFGVFSILNYLNLSHTEVQCEANQKLISIWSHKNPKMAEVAFVFRTQNVLNNIRNKNEQQQLLRDAFQDFGWEASKILELMTGSDDFYFDSATQVKMKSWTKGRVALLGDAGYSASPLSGQGNYLALVGAYIFAGELKKADGNYTRAFSRYNELLHPLVEACHKLGVLVSESFLVPDEVSKEVAEERSNKILQEVKIVSNMISLPEYE	59.17	gnl|BL_ORD_ID|2724|hsp_num:0	3290			804	1137	tetracycline; minocycline; oxytetracycline
BGC0000795.1|S-layer_4 # 1085 # 2017 # 1 # ID=1_4;partial=00;start_type=TTG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.494	BGC0000795.1|S-layer_4 	1085	2017	+	Loose	200	28.4906	vanTr gene in vanL cluster	25.41	3002974	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	TTGAGCGATGTTATAGAAGTCGTAGCGGCCAACGACAGTGATGGCAATGGCTATAGTCTGGCATTAACGAAGGATGGCACCATTTATGCGTGGGGCAGCAATAAATACGGCCAGCTGGGATTGGGCGAAGGAGCAGGAGCCTTTGTTAAAACGCCCACGAGAGTTTTGGAGGTGCGGGACATAGCGTCCATTGCTGGCGGTCAGGGCCACGCGTTTGCCGTAAAAAATGATGGCACGGTTTATGCGTGGGGCCGTAACAATGAAGGTCAGCTTGGCGACGACACGACCAAAGACCGCTACATCCCTGTCCGCATTGATGATTTGAAAGGAATTTCCAGGATCGTCATGGGAACGAACCATATCATCGCTTTTCAACGGAGTGGCAATATGTATGCGTGGGGCAATAACGATTTCGGCCAGCTTGGTAATGGTAGTAATGGTGCTAGTAAAACTCCTGTCCAGGTTAACTTTTTATCCGATGTCCAGCAGCTCTTTACGGTTGGAGACAGCAATTTTGCTTTGAAGAGTGATGGAACGGTTTGGGCCTGGGGCAAGAACGATGAAGGACAATTGGGTGATGGAACGAGAGAAAATCGTTTGATGCCTGTAAAAATCGAAGTCCTCACTAAAATCAAGATGATTTCTGTAAGTGAAGATCACGGGCTTGCGCTTGATGAAGACGGAAAAGTCTGGGCCTGGGGCAAAAATAATCAAGGGCAATTAGGCATAGGAAAAACAGAAGGAAAGGAAAGCAGCGTGCCTGTTCAGGTTGGCAAACTATCAAATATCAAACAAGTATATGCGAAGTCCGGCAGCAGTTTCGCCATTGGAGAGGACGGAACGGTCTGGGCCTGGGGCGAAAACGGAGCAGGGCAACTAGGGGAAGGAACCGCCAAGAACCAGCCGGCTCCCGCAAAAACCCCTACATTTTAG	MSDVIEVVAANDSDGNGYSLALTKDGTIYAWGSNKYGQLGLGEGAGAFVKTPTRVLEVRDIASIAGGQGHAFAVKNDGTVYAWGRNNEGQLGDDTTKDRYIPVRIDDLKGISRIVMGTNHIIAFQRSGNMYAWGNNDFGQLGNGSNGASKTPVQVNFLSDVQQLFTVGDSNFALKSDGTVWAWGKNDEGQLGDGTRENRLMPVKIEVLTKIKMISVSEDHGLALDEDGKVWAWGKNNQGQLGIGKTEGKESSVPVQVGKLSNIKQVYAKSGSSFAIGEDGTVWAWGENGAGQLGEGTAKNQPAPAKTPTF	MVENKMRAYKEFYVESLLHNVQVIKKNIPKSTKIMAVVKANAYGINAVNVAIILEYIGIDFFAVATIDEAIALRKNGITSNILILGYTTPTKVDDLIHYELTQTIVSKEHAYFLNKTGKKIMCHLKVDTGMHRLGVEPTLEEICPIFNYPFLKIKGVYSHLGSADDLSEEGKQRTIKQISRYNTIIAELKRKRVDVGLTHLQSSYGILNYSELAYDYVRPGIILYGLLSNNDHNVKLHLDLQPVVAVKAQLISKKKIAPGEYIGYGTDTQLTSSKTIGVLSIGYADGIPRNLSNGEYCVVFEDKQIPQIGRICMDMMLVDLSNCSDIPLGVMVDVLPNIEEISQIQSTITNEIISCLGSRLGMEVK	84.70	gnl|BL_ORD_ID|4740|hsp_num:0	1510			168	513	vancomycin
BGC0000795.1|S-layer_5 # 2266 # 4917 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=14bp;gc_cont=0.482	BGC0000795.1|S-layer_5 	2266	4917	+	Loose	700	28.8758	ADC-85	28.99	3006442	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	ADC beta-lactamases pending classification for carbapenemase activity	ATGAAGCGTATTACACGTACTATCGTTCCGTTTACGCTTGCCGGACTGCTTAGCGTAAACGGACTTCTACCTGCTGTGGCTGATGCCGCGTCGAATGCTGCATCCGGCCAGTTTAAAGATGTGTCTGCCAATCACTGGGCCAGCCAGTATATTTTGAAGATGGGGCTTCGCGATGTGGTGGCCGGATATAACGACGGAACGTTTAGACCGGACGAAAGTGTAACGCAATTGCAGGCGCTGGCGATGGTTGTCCGAAATATGGGACTTACGGAAGAAGCGAAAAAATACGAGAGTACGGCGATTCCGTACAGTGTGCCGGACTGGGCAAAAGGTTCCGTTGCGCTGGCGATTTCCAAAGGTCTGATTAAGCCAACGGAGAAAAACTTTTATCCAGATATGCCTGCTTCGCGCGCCTGGGTCGCACAGCTTATGGTTCGCATGATTGACAAGGAGTCGGAAGTAGGCAAAGCATCTTCCACCTTGTTTACCGACGGATCAAGCATTCCGGATTGGGCGAAGGGGTATGTAGATGTAGCTGTTGCGAATGACTTAATCTCCGGATACAAAGAAGGAGCAGGAACGGCTTTCAAGCCGAACCGTGCCGTAACGCGCGCGGAAATGGTCACCATGCTCAGCAAGGGAGAACGTTTCCTTAAGATTGAATCGGCTAACACCCGCATCGGTTATCTGCAAAGCGTAAGCGGCAATACGTTAACGCTGACCGATGAGTCAGGCAAGGAACAGTACCGCTATACCATTACAAGCGACACCCAGTTTTATAACGGAAATGTAAAGACAACATCCGCTAATCTGGGAACGGACAGTCAATTGCTCGTTATTAGTGAAAATGGACAGGCTCGATACGTGGAAGTCATCAACTTTAAACAAAAGTCGAAATATGACAAAGCGGTACTGGAAAAAGTGTTTATAGAAGCCAACACGGTTGTATTGCGCCTGGCTGATGGAAAATTGCAAACTTATACGATCGCCAAGGATGCGGTAATCGGAGCAGGAATGGACAGGCTTAAGCTTTCCGATTTTGTGAACGGCGATGAGGTAGAATTCAGATTGAACACGGATGGACAGGTTTCTGAATTGTTCCGTACGGGCTTAAGCAAGGCACAAAGCTTGCAAGGCAGTGTCTATGATGTCGACAAGCAAAACAAATTGCTGACGATTAAAGCGTCCAGCGGAAAACTGGAGACGTACCAGTACAGTGATATTACGTATGTCGAATACAAAGGCAAGCGGTTCCCGAGCATCGAAGATTTACTTCCGGGCGATGAGGTTAAGCTGGAGCTGACGAACGGCATCGTCAGCAAGGTTGTTGTCGAAGCGGAAGCCGGCAAAACAAATGGGGGAGACGTTGGAACGGTTAAGGCGATCAGCGATAAGGATCGATTCGTAACTCTGCAAGGTGAAGATGGAAAGATTCAGGCATATACGGTTGCACAGAACGCCATTATTACGCTAAACGGTGCGCTTGCGCCTACGCTGGCGGACGTGAAAGTCGGCGACAAAGTGGAATTTAAAGTACAGAAGGATATGATTACGTCACTGGCTGTGAAGAATCGTACCGTCTACAACAATAAAGACTTATTGTCCGGCAGCATCTTTGCTCTGGATAAAAAGAACCGTATTCTTTCGCTGAAGACCACCAACGGTGAACTCAAGGCGTACGAGGTCGTTTCCAACGCGGAGATTTTGATTAACGGTTCATCGAAAAAAGAGCTGGATGCACTGGATAAGGATATGAACGTTTCGATTCAGCTGAACGAAGACAACAAAATTATCTATATTAACGCCGATAACCGCGTCCGGGCCGAAGTGGTACGCGTAAATACGGATGATAAGTTGTTGACAGTGAAGCTGGCAACAGGCGAAACGAAAGTATACGTAGTTGATCCGAAGGTAGATATTACGATTTACGATGTGCGCGGTGAGGATCTGCGCGATCTGCGGATTGGCGACAAGATCGCGATGAAGATGAATGGAAACAAGATTACGGATATTGAAGTGGAACGCTCGTTCGTTTACCGTGTTACAGAAAATGGGGGCACATACTCGAATCGCCTCACCGTACAGGATGAAAATGGAAGATCGCATGATGTCATCATCGATAGCCGCGTGACCTTCTCCATTCCGGGTATCCCGTACCCCAGAGTGTCTGATGTGAAGAAGGGCGATGTGCTACGGGCCACATATTTGGGTGATGATCTCAAAGAAATTGCGATTGTGCCGAACGTATATGGACAAGTTGTATCTGTGTCTCCGGAAATGGGCCGGATTGTGGTGCGTGACTTAAACGGCGTGACCAGCGAAGTGACTGCCGCATATGGAACAACGATTCAGATTGGCGACCGCCAATATACGAATATCAACGTTTTGAAACCGGGTGATCGTGTACAGGTGGCAGAGGCAACCAATGGCGCGAAAAGTATCGTTGTACTGACGAAAGTCGAGACTACCTTTAATTCGCTTGATCCGCTGGGCGACCGAATCTATACCGCGAAGCAAAGCTACTACCTGCCGGACAGCCTGTTTAACCGTCAGGTCAACCTGCAATCGCTGTTGCGCGGTCTGCGTAAAGGTGACAACGTAGCGATTTACCTGCTGAATAATGAAGTGTACGAAATAGAGAAGGTAAATTAA	MKRITRTIVPFTLAGLLSVNGLLPAVADAASNAASGQFKDVSANHWASQYILKMGLRDVVAGYNDGTFRPDESVTQLQALAMVVRNMGLTEEAKKYESTAIPYSVPDWAKGSVALAISKGLIKPTEKNFYPDMPASRAWVAQLMVRMIDKESEVGKASSTLFTDGSSIPDWAKGYVDVAVANDLISGYKEGAGTAFKPNRAVTRAEMVTMLSKGERFLKIESANTRIGYLQSVSGNTLTLTDESGKEQYRYTITSDTQFYNGNVKTTSANLGTDSQLLVISENGQARYVEVINFKQKSKYDKAVLEKVFIEANTVVLRLADGKLQTYTIAKDAVIGAGMDRLKLSDFVNGDEVEFRLNTDGQVSELFRTGLSKAQSLQGSVYDVDKQNKLLTIKASSGKLETYQYSDITYVEYKGKRFPSIEDLLPGDEVKLELTNGIVSKVVVEAEAGKTNGGDVGTVKAISDKDRFVTLQGEDGKIQAYTVAQNAIITLNGALAPTLADVKVGDKVEFKVQKDMITSLAVKNRTVYNNKDLLSGSIFALDKKNRILSLKTTNGELKAYEVVSNAEILINGSSKKELDALDKDMNVSIQLNEDNKIIYINADNRVRAEVVRVNTDDKLLTVKLATGETKVYVVDPKVDITIYDVRGEDLRDLRIGDKIAMKMNGNKITDIEVERSFVYRVTENGGTYSNRLTVQDENGRSHDVIIDSRVTFSIPGIPYPRVSDVKKGDVLRATYLGDDLKEIAIVPNVYGQVVSVSPEMGRIVVRDLNGVTSEVTAAYGTTIQIGDRQYTNINVLKPGDRVQVAEATNGAKSIVVLTKVETTFNSLDPLGDRIYTAKQSYYLPDSLFNRQVNLQSLLRGLRKGDNVAIYLLNNEVYEIEKVN	MRFNKISCLLLSPLFIFNTSIYAGNTPKEQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNNKKYETYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGAYAKNKGKISFKDTPGKYWKELKNTPIDQVNLLQLATYTSGNLGLQFPDEVQTDQQVLTFFKDWKPKSSIGEYRQYSNPSIGLFGKVVALSMNKPFDQVLEKTIFPDLSLKHSYVNVPKTQMQNYAFGYNQQNQPIRVNPGPLDGPAYGVKSTLPDMLGFVHANLNPQQYPADIQRAINETHKGFYQVGTMYQALGWEEFSYPATLQTLLDSNSDQIVMKPNKVTAISKEPSVKIFHKTGSTNGFGTYVVFIPKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK	230.55	gnl|BL_ORD_ID|3272|hsp_num:0	4341			243	639	
BGC0000795.1|S-layer_6 # 4958 # 5092 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=8bp;gc_cont=0.363	BGC0000795.1|S-layer_6 	4958	5092	+	Loose	600	22.7126	BRO-1	53.85	3004761	protein homolog model	n/a	n/a	penam	antibiotic inactivation	BRO Beta-lactamase	ATGATTCGATGTGAAATGCGCGTTTATTCAGGGCATACAGTTCAAATAAACAAAGCGAAAAAATTTTTTGACCGCAACAAACCGCTGCGGTTGACGTCTAATAAAATGACGAGTAAAATTATTACTCGGAAATGA	MIRCEMRVYSGHTVQINKAKKFFDRNKPLRLTSNKMTSKIITRK	MQRRHFLQKTLLALPIIFSGNLLTGCKTNLSDDYLPDDKITNNPNLLQNKLKEILPIWENKFNAKIGMTIIADNGELSSHRGNEYFPVNSTIKAFIASHILLLVDKEKLDLNEKIIIKESDLIEYSPVCKKYFDENKPISISELCEATITLSDNGSANILLDKIGGLTAFNQFLKEIGADMVLANNEPLLNRSHYGETSDTAKPIPYTKSLKALIVGNILSNQSKEQLITWLINDKVADNLLRKYLPKNWRIGDKTGTGSESKNIIAVIWNENNKPYFISLFITQPHDGKSLDFKNQKDEIMAQIGKEIYPFL	14.06	gnl|BL_ORD_ID|2375|hsp_num:0	3565			387	426	
BGC0000795.1|S-layer_7 # 5089 # 5364 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.522	BGC0000795.1|S-layer_7 	5089	5364	+	Loose	500	24.6386	MSI-OXA	25.68	3003719	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	MSI-OXA family beta-lactamase	ATGATTTACTTTCCTGCTGATTTTTGCAGGATGTTCCGGAGTGAAGAAATTGCTGGACTATTTAATTACGTCGAAAACGCGGATCAAACTTTTGCTGAAGTTTTTTTTGAACGCAGAAGCGCGCGGCTATTTGCGTTCGCTGGCGGAAGAGTTCGGCGAGTCGACCAACGCGGTGCGCGTGGAACTGAACCGGCTGACAGAAGCGGGCTTGCTGGAGGCAGAAAGCGAAGGCCGGACGAAAGTGTACCGCGCCAACCGTGGTCACGCGCTATTTGA	MIYFPADFCRMFRSEEIAGLFNYVENADQTFAEVFFERRSARLFAFAGGRVRRVDQRGARGTEPADRSGLAGGRKRRPDESVPRQPWSRAI	MSHTFIIDRLGASMIKQILAALLLISPLLAQAAEWKESAQVARLFKQEGVSGTFVVYDVAADSYTVHDRQRANTRFIPASTFKIPNTLIALAHGAVANVDEVVPYGGKPVARPEWARDMGLREAIRISNVPVYQEVARRVGLDRMRSELVRMKYGNMQTGTVVDRFWLDGPLKISAVEQTEFLTKLAQGTLPFTNVAMAAVREISRQDGAPELYAKTGWGSRPGEADIGWWVGWLKKDGKLYAFALNMDLPDGAQDKRVSLAKAALRELGLL	33.46	gnl|BL_ORD_ID|2031|hsp_num:0	2234			114	336	
BGC0000795.1|S-layer_8 # 5330 # 5674 # 1 # ID=1_8;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.383	BGC0000795.1|S-layer_8 	5330	5674	+	Loose	350	24.6386	BcIII	37.5	3007101	protein homolog model	n/a	n/a	cephalosporin; penem	antibiotic inactivation	class A Bacillus cereus Bc beta-lactamase	GTGTACCGCGCCAACCGTGGTCACGCGCTATTTGAGGACTTACATAATATTGTAAAGAAATACATAGGCATTGATCAGTTAATTGAAGAGGTATTGCGTAAACTTGGAAATGTGGAGCTTGCACTTATTACTGGTGATTACGCAAAAGGGATTGACTCCGGGATTATTGATTTGGTGATTGTAGGCGGAGTTGATAAGGGGTATTTACAGGTGTTAGTAGAGAAAGCGGAAGAGTTAATTCGTAGGAAGATTCGGATATTGATATTAAATAGGCAAGGGTTTGAAAAGTTAAAAGGGAAGTTTGAAGAAGAGAATGCGTTAGTAGTGTGGAATCAATTAAAATAA	MYRANRGHALFEDLHNIVKKYIGIDQLIEEVLRKLGNVELALITGDYAKGIDSGIIDLVIVGGVDKGYLQVLVEKAEELIRRKIRILILNRQGFEKLKGKFEEENALVVWNQLK	MFVLNKFFTNSHYKKIVPVVLLSCATLIGCSNSNTQSESTKQTNQTNQVKQENIGNHAFAKLEKEYNAKLGIYALDTSTNQTVAYHADDRFAFASTSKSLAVGALLRQNSIEALDERITYTREDLSNYNPITEMHVDTGMTLKELADASVRYSDSTAHNLILKKLGGPSAFEKILRKMGDTVTNSERFEPELNEVNPGETHDTSTPKAIAKTLQSFTLGTVLPSEKRELLVDWMKRNTTGNKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLSILSNHDKEDAEYDDTLIADATKIVLETLKVTNK	36.08	gnl|BL_ORD_ID|4780|hsp_num:0	5775			471	543	
BGC0000795.1|S-layer_9 # 5742 # 6713 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GAGG;rbs_spacer=9bp;gc_cont=0.373	BGC0000795.1|S-layer_9 	5742	6713	+	Loose	500	25.409	CTX-M-38	32.43	3001900	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	CTX-M beta-lactamase	ATGAAAAAAGCTTTAATTACAGGAATTACAGGACAAGATGGCTCTTATTTAGCAGAACTACTATTAGAAAAAGGATATGAAGTGTACGGTTTAATTCGTCGCACTAGTACTCCTATTATGGTTAATATCGAGCATTTAAAAGATAAAATCACACTAGTTTCCGGTGATCTGACAGATTTATCTTCGCTAGTGGCAATTATAAAAAAGATTCAACCGGATGAAGTATATAACTTAGGAGCGCAATCTTTTGTAGCAACATCATGGGAACAGTCTATTTTAACTGGTCAAGTAACGGCGCTGGGAGTTACAAATATTTTAGAGGCATTGCGAATGGAAAAACCAGATGCTAAGTTTTATCAAGCATCTTCTAGTGAAATGTTTGGAAAAGTTGTTGAAATGCCACAAAAAGAAACGACTCCATTTTATCCGCGTAGCCCATATGGTGTAGCAAAAGTATACGGACACTGGATTACTGTGAATTACCGCGAGAGTTTTGATATGTTCGCATGTTCAGGGATTTTATTTAATCACGAATCTCCGAGACGTGGTATAGAATTCGTTACACGTAAAATTACAGACGGGGTAGCGAGAATTAAACACGGTTTACAAAAAGAACTTCGTCTTGGGAACTTGGATGCACAGCGTGATTGGGGCTTTGCAAAAGACTATGTTGAATGTATGTGGTTGATGTTACAGCAAGAAAAAGCAGATGATTATGTGATTGCGACAGGAGAAATGCATTCCGTTCGTGAATTCTGTGAGATTGCTTTTGGACATGTAGGGCTGAATTATGAGGATTACGTAGTTGTTGATCCAAAATTCTTCCGGGCTGCCGAGGTAGATGTATTGTTGGGAGATGCTAGTAAAGCAATTAACAAACTAGGATGGAATCCACGTAAAACATCTTTTGAACAATTAGTAACAATGATGGTGGATAATGATATGGATTTAATCCGTAAACAGTTAAAATAA	MKKALITGITGQDGSYLAELLLEKGYEVYGLIRRTSTPIMVNIEHLKDKITLVSGDLTDLSSLVAIIKKIQPDEVYNLGAQSFVATSWEQSILTGQVTALGVTNILEALRMEKPDAKFYQASSSEMFGKVVEMPQKETTPFYPRSPYGVAKVYGHWITVNYRESFDMFACSGILFNHESPRRGIEFVTRKITDGVARIKHGLQKELRLGNLDAQRDWGFAKDYVECMWLMLQQEKADDYVIATGEMHSVREFCEIAFGHVGLNYEDYVVVDPKFFRAAEVDVLLGDASKAINKLGWNPRKTSFEQLVTMMVDNDMDLIRKQLK	MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQVLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTMTLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAARIRAGLPTSWTVGDKTGSGDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL	111.00	gnl|BL_ORD_ID|175|hsp_num:0	192			651	759	
BGC0000795.1|S-layer_10 # 6734 # 7663 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.358	BGC0000795.1|S-layer_10 	6734	7663	+	Loose	1300	28.8758	mdtO	23.81	3003549	protein homolog model	n/a	n/a	nucleoside antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAGAGCCCTAATCACTGGAGTTGCAGGCTTCGTAGGCAAATATTTAGCTAACCATCTAACTGAGCAAAATGTAGAAGTTTTTGGGACATCTAGAAATAATGAAGCAAAATTACCTAACGTTGAAATGATATCATTAGATATTATGGATTCTCAAAGGGTTAAAAAGGTAATCTCTGATATTAAGCCAGACTATATTTTTCATCTTGCAGCCAAGAGTTCTGTTAAGGACTCTTGGCTTAATAAAAAGGGGACATTTTCTACAAATGTATTTGGTACTTTGCATGTATTGGATGCAGTTCGCGACAGTAATCTAGATTGTCGTATACTGACCATAGGATCTTCTGAAGAGTATGGAATGATATTACCAGAAGAATCACCTGTATCGGAAGAGAACCAATTACGTCCTATGAGTCCTTATGGTGTAAGTAAAGCTTCTGTTGGGATGCTTGCTAGACAATATGTCAAAGCATATGGGATGGATATTATTCATACGAGAACATTTAATCATATTGGCCCGGGTCAAAGTTTAGGTTTTGTTACGCAGGATTTTGCTAAACAGATTGTTGATATTGAGATGGAAAAGCAGGAACCAATTATAAAAGTTGGAAATCTAGAGGCTGTTCGTGATTTTACCGATGTACGCGATATTGTGCAAGCATATTGGTTATTATCTCAATATGGAAAAACAGGTGACGTATATAATGTATGTTCTGGAATTGGCACAAGGATTCAAGATGTTCTTGACTTATTACTAGCTATGGCTAATGTGAAAATTGATACTGAGTTAAATCCGTTACAATTAAGACCTTCTGAGGTTCCAACTCTTATAGGTTCTAATAAAAGATTGAAGGATTCTACAGGGTGGAAACCAAGAATTCCTCTTGAAAAGTCTTTATTCGAGATTTTACAAAGTTACCGTCAAGCATAA	MRALITGVAGFVGKYLANHLTEQNVEVFGTSRNNEAKLPNVEMISLDIMDSQRVKKVISDIKPDYIFHLAAKSSVKDSWLNKKGTFSTNVFGTLHVLDAVRDSNLDCRILTIGSSEEYGMILPEESPVSEENQLRPMSPYGVSKASVGMLARQYVKAYGMDIIHTRTFNHIGPGQSLGFVTQDFAKQIVDIEMEKQEPIIKVGNLEAVRDFTDVRDIVQAYWLLSQYGKTGDVYNVCSGIGTRIQDVLDLLLAMANVKIDTELNPLQLRPSEVPTLIGSNKRLKDSTGWKPRIPLEKSLFEILQSYRQA	MSALNSLPLPVVRLLAFFHEELSERRPGRVPQTVQLWVGCLLVILISMTFEIPFVALSLAVLFYGIQSNAFYTKFVAILFVVATVLEIGSLFLIYKWSYGEPLIRLIIAGPILMGCMFLMRTHRLGLVFFAVAIVAIYGQTFPAMLDYPEVVVRLTLWCIVVGLYPTLLMTLIGVLWFPSRAISQMHQALNDRLDDAISHLTDSLAPLPETRIEREALALQKLNVFCLADDANWRTQNAWWQSCVATVTYIYSTLNRYDPTSFADSQAIIEFRQKLASEINKLQHAVAEGQCWQSDWRISESEAMAARECNLENICQTLLQLGQMDPNTPPTPAAKPPSMAADAFTNPDYMRYAVKTLLACLICYTFYSGVDWEGIHTCMLTCVIVANPNVGSSYQKMVLRFGGAFCGAILALLFTLLVMPWLDNIVELLFVLAPIFLLGAWIATSSERSSYIGTQMVVTFALATLENVFGPVYDLVEIRDRALGIIIGTVVSAVIYTFVWPESEARTLPQKLAGTLGMLSKVMRIPRQQEVTALRTYLQIRIGLHAAFNACEEMCQRVALERQLDSEERALLIERSQTVIRQGRDLLHAWDATWNSAQALDNALQPDRAGQFADALEKYAAGLATALSRSPQITLEETPASQAILPTLLKQEQHVCQLFARLPDWTAPALTPATEQAQGATQ	45.24	gnl|BL_ORD_ID|1893|hsp_num:0	2056			1329	1773	acriflavine; puromycin
BGC0000795.1|S-layer_11 # 7835 # 8464 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.329	BGC0000795.1|S-layer_11 	7835	8464	+	Loose	750	26.9498	mdtH	31.58	3001216	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAGAGCTAAACTCCCTGAGATTGATAACTCATTGGCGTATAGTATTTATATGTGTGCAGGACTACTGCCATGGAATTATTTTATTGAAACATTACAACGTTTTCAAAATGTATTTTTAGAACAGGGGAACTTATTGAAGAAAGTGAGCTTTCCGCGAACTTCATTACCTATTTATGTGGTGATATCTTCGACGATTAACTTTAGTATTATTTTTGGTTTGTTTATTGTGTTTTTGTTAATAACAGGCCAGTTCCCAGGTTGGTATTTTCTTGGTGTTTTTCCTCTTTTGTTATTGCAGCAAATGTTTGCTGTAGGAATAGGGATGTTCCTTGGAACAATAAATGTATTCTTTAGAGATATAGGGCATGCGTTTGGCGTGTTTTTGCAATTCTGGTTCTGGTTAACGCCTATTGTCTATCCTATCAAAGCTGTTCCTGAGAAATTTAAATCTATTTTTGAATTAAATATTATGTATCCAATAGTTAAGTCATTTCAAACTATTTTTGTTTATCAAAAATGGCCACAATGGAATGAGCTATTCATTCCGTTTTTAGGTGCTTTAATTATGATGTTATTAGGGTATGTGACTTTTAAAAAGCTGGAAAAAGAAATGGTGGACGAGATTTAA	MRAKLPEIDNSLAYSIYMCAGLLPWNYFIETLQRFQNVFLEQGNLLKKVSFPRTSLPIYVVISSTINFSIIFGLFIVFLLITGQFPGWYFLGVFPLLLLQQMFAVGIGMFLGTINVFFRDIGHAFGVFLQFWFWLTPIVYPIKAVPEKFKSIFELNIMYPIVKSFQTIFVYQKWPQWNELFIPFLGALIMMLLGYVTFKKLEKEMVDEI	MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQGLGIFGGAIADRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCLLSGLGGTLFDPPRSALVVKLIRPQQRGRFFSLLMMQDSAGAVIGALLGSWLLQYDFRLVCATGAVLFVLCAAFNAWLLPAWKLSTVRTPVREGMTRVMRDKRFVTYVLTLAGYYMLAVQVMLMLPIMVNDVAGAPSAVKWMYAIEACLSLTLLYPIARWSEKHFRLEHRLMAGLLIMSLSMMPVGMVSGLQQLFTLICLFYIGSIIAEPARETLSASLADARARGSYMGFSRLGLAIGGAIGYIGGGWLFDLGKSAHQPELPWMMLGIIGIFTFLALGWQFSQKRAARRLLERDA	51.99	gnl|BL_ORD_ID|342|hsp_num:0	375			0	219	enoxacin; norfloxacin
BGC0000795.1|S-layer_12 # 8464 # 9690 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=5bp;gc_cont=0.352	BGC0000795.1|S-layer_12 	8464	9690	+	Loose	600	92.4337	oleC	30.19	3003748	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGTCTAGAATTGAGGTTAAGAACCTAGGGAAAAAGTATAAAAAATATGCTAGAAAATGGCATAGACTGTTTGAGTGGATAACTGGTCGTAAAAAACATGAGGAAAAATTTGTTTTAAAGGGGTTATCTTTTAATGTTTTAGAAGGGGAATCCGTTGGCATTATAGGACATAATGGTGCTGGGAAAAGTACATTGTTAAAGATTTTAACAGGTACAACACAGCCTTCGGAAGGAGAATTTAAAGTTAATGGAAGGGTGGCAGCTTTACTTGAGTTAGGCATGGGCTTTCATCCTGATTTTACAGGCATACAAAATGTATATATGTCTGGACAATTAATGGGTTTATCAAATGAAGAGATTACAAGATTGCTTCCTGAAATTGAAAGATTTGCTGAAATTGGAGATTATATTCATCAGCCGTTGAGAACATATTCAAGCGGTATGGCTGTTCGTTTAGCTTTTTCGGTAGCGACCGCTATAAGACCAGATGTTTTAATTGTTGATGAGGCTTTATCTGTAGGAGATGCCTATTTTCAACATAAATGCTTTGATAGAATAAAAAAGTTTCGTAGTGAGGGAACGACAATTTTATTTGTTTCACATGATCCTGGTGCCGTCAAAAATCTTTGCGATCGAGCAATTCTTTTAGATCAGGGGATAATGATTAAAGAAGGGACACCTGAAGAGGTACTGGATTATTATAATGCAATTATTGCCAAGCGTGAAGCAGATTATAATATTAAGCAGAGCATAGGTAAAGATGGAAAAGTAGATACTAGATCTGGTAACGGTGATATTAAAATTGAAAAAGTTGAGTTGTTTTCTGGCAATCGTAAGGTGAATGCTGTCCAAGTAGGGGAAGAAATAGAGATAAAAATTGATTTGAAATGTATGAAAAAAATTGATTGTCCAACTGTTGGATTTATGTTTAAAGATAGGTTAGGGAACGAAGTGTTCGGGACGAATACTTACTACTTAAAAAAGAATATAGAAAGTTTACAAATCGGTGAAAAATTTTCTGTTATATTTAAAATTCCTGCTAATTTTGGTATAGGAAATTATAGTTTAACTGTAGCAGCACACGAGGGGCATACACATACAGCGAAGAACTACGAATGGTGGGATCATGCTGCTTTATTACAGGTTGTTCCGGGTGACGAGGCTCCGTTTGTAGGTGTGTGTTATTTAAAAGCTACAGTAGAGTTTAGTAAAGGAGTAATGGTTTAA	MSRIEVKNLGKKYKKYARKWHRLFEWITGRKKHEEKFVLKGLSFNVLEGESVGIIGHNGAGKSTLLKILTGTTQPSEGEFKVNGRVAALLELGMGFHPDFTGIQNVYMSGQLMGLSNEEITRLLPEIERFAEIGDYIHQPLRTYSSGMAVRLAFSVATAIRPDVLIVDEALSVGDAYFQHKCFDRIKKFRSEGTTILFVSHDPGAVKNLCDRAILLDQGIMIKEGTPEEVLDYYNAIIAKREADYNIKQSIGKDGKVDTRSGNGDIKIEKVELFSGNRKVNAVQVGEEIEIKIDLKCMKKIDCPTVGFMFKDRLGNEVFGTNTYYLKKNIESLQIGEKFSVIFKIPANFGIGNYSLTVAAHEGHTHTAKNYEWWDHAALLQVVPGDEAPFVGVCYLKATVEFSKGVMV	MTVRGLVKHYGETKALDGVDLDVREGTVMGVLGPNGAGKTTLVRILSTLITPDSGQATVAGYDVVRQPRQLRRVIGLTGQYASVDEKLPGWENLYLIGRLLDLSRKEARARADELLERFSLTEAARRPAGTYSGGMRRRLDLAASMIGRPAVLYLDEPTTGLDPRTRNEVWDEVKAMVGDGVTVLLTTQYMEEAEQLASELTVVDRGRVIAKGGIEELKARVGGRTLRVRPVDPLQLRPLAGMLDELGITGLASTTVDTETGALLVPILSDEQLTAVVGAVTARGITLSSITTELPSLDEVFLSLTGHRASAPQDAEPARQEVAV	125.54	gnl|BL_ORD_ID|2050|hsp_num:0	2264			21	654	oleandomycin
BGC0000795.1|S-layer_13 # 9690 # 11093 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=12bp;gc_cont=0.319	BGC0000795.1|S-layer_13 	9690	11093	+	Loose	300	34.2686	Erm(37)	30.91	3000392	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGAAAATCGAATTTGATGATGCTGAAATTGATGTAAAAGACATAATGAGACAAATTAAAGAGAACGTTTTGGCAAGAGGAGATGTACGAGAAATCCCGGAAAAAGTAGTAGTTAACGGTCAAAATTATCTAACCGAGTTAGAAATAGAGCAACATTTATTACAAAAAACCTGGGATTATTCATTAGATTATCCTATCAAATCGAACCGTAAAGTTATTGGTCGGTTAATCGTATTTTGTAAGAGGTTAATTCGTAAGCTAATTCACTGGTATGTGAATCCGGGTGTAAAAAAGCAAATAAATTTCAATGCAAATGTTGTTCGTACTCTTAATCCTCTTATTGAACAAGTTAAGCAAATAACAGATTATAATGAAAGTCTAGAACAAAAGCTAGAACAAAAGTTAGAACAAAAGCTAGAACAAAAGTTAGAACAAAAGCTAGAACAAAAGCTAGAACAAAAGCTAGAACAAAAGTTAGAACAAAAGCTAGAACAAAAGTTAGAACAAAAGCTAGAACAAAAGTTAGAACAAAAGCTGAAACAGAGACTAAAACTTTTTGATGAAGAACAGAAAAACACTATACAACCTATTTATCATACAATAAGAGTACAAACAGAGAGATTGCGTCGGATTGAGAGAATGTTGAAAAATAAAGAAAGTAAAGTTTTAACTTCAAATGAGAATATAGACGTAGTTTCTTTAGAAGAAAAAATTAAGGAAACGGACACAGAATTTGACTACTATTTATTTGAAGAATATTACAGAGGTTCTCGAGAAGAGATTATAAATAGACAAAAGAAGTATCTAAAGTATTTTTCTGAGGGACAGTATGTTTTAGACCTTGGATGTGGGCGTGGAGAATTCACAGAACTTTTGCTTTCTAAGGGAATAAAAGTTACTTGTGTAGATATAGATGAAGACATGGTAGCATATTGCAAGGATCGTGGTTTTCCGATAGTTAAAAGTGATTTGTTTTCCTATTTAAATTCTGTTCCTGATCGTTCGGTAGATGGTATTTTCTTAGGACAAGTTATTGAACATTTAACAACCGAACAATTTATCTCACTTGTAAATATCTCTTATAGGAAGTTAAAACCAATGGGCTACTTTATTGCGGAGACACCAAATCCACGTAGTCTATCAATTTTTGCACAGAGCTTTTATATGGATCCTACCCATGTAAAGCCAGTTCATCCATATACCTCAAAGTTTGTTTTAGAATCAGCAGGTTTCTTTGATGTTGAGATACATTATTTTTCTCCAAATCATGAAAGTACACAACTTCCATACTTGGAATTAGAGGGTGTTAAGTCAAATTCACTAGATAAATTTAATCAGGTTTTGCAAGTCTGGAATGAGATAATTTTTGGTAATCAAGATTATTATGTTGTAGGAAGGAAGTAA	MKIEFDDAEIDVKDIMRQIKENVLARGDVREIPEKVVVNGQNYLTELEIEQHLLQKTWDYSLDYPIKSNRKVIGRLIVFCKRLIRKLIHWYVNPGVKKQINFNANVVRTLNPLIEQVKQITDYNESLEQKLEQKLEQKLEQKLEQKLEQKLEQKLEQKLEQKLEQKLEQKLEQKLEQKLKQRLKLFDEEQKNTIQPIYHTIRVQTERLRRIERMLKNKESKVLTSNENIDVVSLEEKIKETDTEFDYYLFEEYYRGSREEIINRQKKYLKYFSEGQYVLDLGCGRGEFTELLLSKGIKVTCVDIDEDMVAYCKDRGFPIVKSDLFSYLNSVPDRSVDGIFLGQVIEHLTTEQFISLVNISYRKLKPMGYFIAETPNPRSLSIFAQSFYMDPTHVKPVHPYTSKFVLESAGFFDVEIHYFSPNHESTQLPYLELEGVKSNSLDKFNQVLQVWNEIIFGNQDYYVVGRK	MSALGRSRRAWGWHRLHDEWAARVVSAAAVRPGELVFDIGAGEGALTAHLVRAGARVVAVELHPRRVGVLRERFPGITVVHADAASIRLPGRPFRVVANPPYGISSRLLRTLLAPNSGLVAADLVLQRALVCKFASRNARRFTLTVGLMLPRRAFLPPPHVDSAVLVVRRRKCGDWQGR	260.89	gnl|BL_ORD_ID|421|hsp_num:0	468			93	258	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
BGC0000795.1|S-layer_14 # 11101 # 12162 # 1 # ID=1_14;partial=00;start_type=TTG;rbs_motif=AGG;rbs_spacer=13bp;gc_cont=0.310	BGC0000795.1|S-layer_14 	11101	12162	+	Loose	100	26.5646	FosA8	27.69	3007371	protein homolog model	n/a	n/a	phosphonic acid antibiotic	antibiotic inactivation	fosfomycin thiol transferase	TTGATAATTAATCAACTATTACCTTCTATCAGTCCCGGAGATGCGGTTAGTAATAGCGTCTTAAATATAATGAATTTGTTAAATGAAATGGGTTTTGATTCCAAGATTTATGCCGAATCAATTCATCCTGCAATGCAAGAGGTTGCTTTGCCTATAAGTAGTTGCCCAAAGGATTGTTCTTTGATTTATCATATGGCGATTGGTTATCCATTTGCATATAAACTGCCTAATTTTAAGGGAAAAAAAATTCTTATTTATCATAATATCACTCCTGATGTTTTTTTTAGAGATTATAAAGAAATTCAGGAGCTTTGTATAGAAGGTAGAAGACAATTAAAGTTTTTAGTACCATATATTGATTATGCTTGGGCTGATTCTGAATATAATCGATTAGAGTTAGAGGAATTGGGCTATAAAAATACACATGTAACACCAATTATTATAAACTTCGAAGATTATAAAAGAAATCCAAGTCAAAAGCTGATGGAAAAATTCAAAGCAGAAAAGCATATAACTAATATTTTATTTGTTGGTCGTATAGCCCCTAATAAAAAACAAGAAGATATTATCAAAGTGTTTTATTATTATAAAAAATATATTAATGAAGATTCTCGCTTGTTTTTGGTAGGTTCTTATAGTGGGATGGAGAGGTACTATAATGAGCTTATGGAGCTTGTTAAAGAGTTGCAGTTAGAAGATGTGTATATAACAGGACATATTTCGTTTGAAGAGATATTGGCTTATTATACAAACGCGGATCTTTTTTTATGTATGAGTGAGCATGAAGGGTTTTGCGTGCCGTTAGTTGAAGCGATGCATTTTGAAATTCCTATTATAGCCTACAAGAGTAGTGCAATAGGTGAAACATTAGGGAATGGCGGGATTCTTGTATTAGAAAAGCAATATAAAGAGATTGCAGAGTTAATGCATATCGTATTAAGCACACCTAAGATTAAAGAAAGAATGATTATAAATCAAAAGAAACGTTTAGAGTTTTTTTCTAAAAAGAATACAGAAAATATATTTAGAGAACGCATACAAGAGGTGCTTCTTGGAAGTTAA	MIINQLLPSISPGDAVSNSVLNIMNLLNEMGFDSKIYAESIHPAMQEVALPISSCPKDCSLIYHMAIGYPFAYKLPNFKGKKILIYHNITPDVFFRDYKEIQELCIEGRRQLKFLVPYIDYAWADSEYNRLELEELGYKNTHVTPIIINFEDYKRNPSQKLMEKFKAEKHITNILFVGRIAPNKKQEDIIKVFYYYKKYINEDSRLFLVGSYSGMERYYNELMELVKELQLEDVYITGHISFEEILAYYTNADLFLCMSEHEGFCVPLVEAMHFEIPIIAYKSSAIGETLGNGGILVLEKQYKEIAELMHIVLSTPKIKERMIINQKKRLEFFSKKNTENIFRERIQEVLLGS	MLNALNHLTLAVSNLPASITFWRDLLGLRLHAEWHTGAYLTCGDLWLCLSYDETRTFIPPQNSDYTHYAFSVEPEHFDAVAQKLKDAGVTVWKENKSEGASFYFLDPDGHKLELHVGDLAARLAACREKPYAGMVFTSDEA	250.35	gnl|BL_ORD_ID|4906|hsp_num:0	5899			111	306	fosfomycin
BGC0000795.1|S-layer_15 # 12152 # 13360 # 1 # ID=1_15;partial=00;start_type=TTG;rbs_motif=GAGG;rbs_spacer=6bp;gc_cont=0.323	BGC0000795.1|S-layer_15 	12152	13360	+	Loose	550	26.5646	blaF	50.0	3003562	protein homolog model	n/a	n/a	penam	antibiotic inactivation	blaF family beta-lactamase	TTGGAAGTTAATAGTGGAGGAGTTGCTATGAAGCGACGGATTGCTTTTGTAGTACAGAGGTATGGATTGGAAGTTAATGGTGGTTCGGAAGCTAGTTGTAGGATGATTGCAGAACGCTTATCTAAATATTATGAGGTAGAAGTATTAACTACAAAAGCTATTGATTATACAACTTGGGCTGATTATTACGAGCATGATATAGAAGAAATAAATGGTGTTTTTGTTCGAAGGTTTTCTACTAATCAAATAAGGAATATGGATAGGTTTGGTTCCATAACTTATGAAATACTAAATAACGATAAGAGAACTGTATATGAAGAGTTAGAGTGGATGAGACAGCAAGGACCAGTTTCTTTTGAAATGATAGAGTATATAAAAAAATATAGTAATCAATATGATGTTTTTATATTTTTTACATATTTATACTTTACTACATTTCATGGTATACAATTAGTTCCAGAAAAGAGTATTTTTGTGCCGACAGCGCATGACGAGCCATATATATATTTTTCTATTTTTCGACCTATATTCCACTTACCACGCTACAATATATTTCTTACAGTTGAGGAACAAGAATTTGTTCATAAGCTTTTTCGTAATTCATACCTTCCATTCGATGTTGCCGGAGTAGGTGTGGATGTTCCACAAAAAATTCTTTCTCAGCAACAATTTAAAGAACAATTTAAAATTGTAGATCCTTATGTTATTTATGTTGGGAGGATTGATGAATCAAAAGGTTGTAAAGAACTCTTTGATTATTTTATGCGTTACAAAGAAGAAACAAGAAATGATTTAAAGCTTGTGTTAATGGGAAAATCGGTTATACATATTCCGAAATGTGAAGACATTATACCCTTAGGATTTGTTTCGGAGGAGGAGAAATTTAGTGGAATTGCTGGAGCTAAGTTTTTAATCATGCCTTCAAAGTACGAAAGTTTATCTATGGTTGTTTTGGAGAGCCTATCTTTAAATAGGCCAGTTCTAGTTAATGAAGAATGCGAAGTTTTAAAAGGGCATTGTGAACGTGGGAATGCTGGCTTATATTACAAGAGTTATGAAGAGTTTAAAACATGTGTAAATCTATTGCTTCAACACGAGCATTTATGTAATAAATTAGGGAAAAATGGGAAAGGGTATGTAGATAAGTATTATAGATGGTCAACCATTATAGATAAATTTATACGAGCAATTGAGAGTATAGTCGTTTAG	MEVNSGGVAMKRRIAFVVQRYGLEVNGGSEASCRMIAERLSKYYEVEVLTTKAIDYTTWADYYEHDIEEINGVFVRRFSTNQIRNMDRFGSITYEILNNDKRTVYEELEWMRQQGPVSFEMIEYIKKYSNQYDVFIFFTYLYFTTFHGIQLVPEKSIFVPTAHDEPYIYFSIFRPIFHLPRYNIFLTVEEQEFVHKLFRNSYLPFDVAGVGVDVPQKILSQQQFKEQFKIVDPYVIYVGRIDESKGCKELFDYFMRYKEETRNDLKLVLMGKSVIHIPKCEDIIPLGFVSEEEKFSGIAGAKFLIMPSKYESLSMVVLESLSLNRPVLVNEECEVLKGHCERGNAGLYYKSYEEFKTCVNLLLQHEHLCNKLGKNGKGYVDKYYRWSTIIDKFIRAIESIVV	MTGLSRRNVLIGSLVAAAAVGAGVGGAAPAFAAPIDDQLAELERRDNVLIGLYAANLQSGRRITHRLDEMFAMCSTFKGYAAARVLQMAEHGEISLDNRVFVDADALVPNSPVTEARAGAEMTLAELCQAALQRSDNTAANLLLKTIGGPAAVTAFARSVGDERTRLDRWEVELNSAIPGDPRDTSTAAALAVGYRAILAGDALSPPQRGLLEDWMRANQTSSMRAGLPEGWTTADKTGSGDYGSTNDAGIAFGPDGQRLLLVMMTRSQAHDPKAENLRPLIGELTALVLPSLL	136.73	gnl|BL_ORD_ID|443|hsp_num:0	395			777	843	amoxicillin
BGC0000795.1|S-layer_16 # 13523 # 13834 # 1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=12bp;gc_cont=0.410	BGC0000795.1|S-layer_16 	13523	13834	+	Loose	600	27.335	SGM-6	38.1	3006992	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	SGM beta-lactamase	ATGACAAGAAGAAAGTATTCGATTGATTTCAAAAAACAAGTGGTGAAAGAAGCGAAAGAGACCGGTAATTTAGCAGCCGTTGCCCGCCGTTATGAGTTATCTGCTAACATGGTGGGGCACTGGAAGCGAGAGTTCGAGAGCGGAAAACATGGAGAAATTGATTTCTCTATGGTTCCGGTCCTTGATGCCGAAGAAGTTGTGAAAGAAAACGAACAACTTAAACGGTTACTTGGCGAACAAGCATTAGAACTTGCGATTTTACGTGATTTGATAAAAAAGAAAAACCCTCACTTGCTGAAAAACTTGAAGTAG	MTRRKYSIDFKKQVVKEAKETGNLAAVARRYELSANMVGHWKREFESGKHGEIDFSMVPVLDAEEVVKENEQLKRLLGEQALELAILRDLIKKKNPHLLKNLK	MALRKSLSLAALTACLVVTLPLSAAPKKKAPAKKAEEVPTLPTLMPPAPRYLVPQSALTSVRNPKEIEEETGGRMGIALVDREGALILGFNRDDRFAMCSTFKAPLAAAVLIGAQGGKFGLEGEIPFTKDDILDYAPVVKKNKKRGRMSMAELAEAAVEVSDNSAANLLLPMLGGPEGLTSFIRAHGDKITRLDRIEPELNENVAGDPRDTTSPAAMAGLMGRLLFRDMQAADADRLRGWLNASTTGDKRIKAGLPEGWTSGSKTGSCGTAYNDVALVKSPAGEEYILAIYLDRPTVDDKKAEAAIAEAAHSALEFVSKAQKSGLD	31.60	gnl|BL_ORD_ID|4579|hsp_num:0	5649			357	483	
BGC0000795.1|S-layer_17 # 14006 # 14269 # 1 # ID=1_17;partial=00;start_type=TTG;rbs_motif=AGG;rbs_spacer=12bp;gc_cont=0.451	BGC0000795.1|S-layer_17 	14006	14269	+	Loose	440	22.7126	WUS-1	60.0	3007435	protein homolog model	n/a	n/a	carbapenem; penam	antibiotic inactivation	WUS beta-lactamase	TTGCGTATCATAATTGGTCTGTCCTGTGAGGCAAAGGATGCGAGTCGTACGGTACAACAGGCATTGTTTAAACGGCAATTATTTGGAGAAACACGTCCCGTTCTTCGTTCCGATAATGGCCCACAGTTTACGTCTCATCATTTTATACAAGCATGTGAAACGTTTGGAATTGTTCATGAGCGTATTCCGCCACGAACACCGAATATGAATGGGCACATCGAAGCGTTTCATCGCATCCTGGAAGATGAATGTCTGGCACGTTAG	MRIIIGLSCEAKDASRTVQQALFKRQLFGETRPVLRSDNGPQFTSHHFIQACETFGIVHERIPPRTPNMNGHIEAFHRILEDECLAR	MRQFLYTIALLTCSFIAHAQSERLKIEKLNDKMYVYTTYQEFNGVQYSSNALYVVTDDGVLLIDTPWDKEQYEPLVNHIKQAHNKEIKWVITTHFHEDRSGGLDYFNKAGAQTYTFVQTNEMLKERNEPQAQHTFDKERHFTFGNDKLTVYFLGEGHTKDNTVVWFPQEKILYGGCLIKSAEATSIGNIADANVNAWPKTIKAVKRKFKKVKSIIPGHDQWNLSGHIENTERILEEYHRDNLNKNN	35.37	gnl|BL_ORD_ID|4941|hsp_num:0	5933			663	708	carbenicillin; imipenem; ampicillin
BGC0000795.1|S-layer_18 # 14445 # 14603 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.327	BGC0000795.1|S-layer_18 	14445	14603	+	Loose	500	23.0978	cmrA	33.33	3002702	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAATAAGGTTGTTTGTGTCCAAGTAATGGGGGTTAATCCGGCCTCTTTGCTTGGAATGCAAGGAGGGAAGTTTGTTAATGAAAATTTTTCCTGGGACATTATTGTAAAGAAATATAACAATTTCTTTTCTGAATTATATAGAGATATGTCTGAATAA	MNKVVCVQVMGVNPASLLGMQGGKFVNENFSWDIIVKKYNNFFSELYRDMSE	MPFAIYVLGLAVFAQGTSEFMLSGLIPDMARDLGVSVPAAGLLTSAFAVGMIIGAPLMAIASMRWPRRRALLTFLITFMLVHVIGALTSSFEVLLVTRIVGALANAGFLAVALGAAMAMVPADMKGRATSVLLGGVTIACVAGVPGGAFLGEIWGWRAAFWAVVVISAPAVVAIMFATPAEPPAESTPNAKRELSSLRSRKLQLMLVLGALINGATFCSFTYMAPTLTDISGFDSRWIPLLLGLFGLGSFIGVSVGGRLADTRPFQLLAVGSAALLTGWIVFALTASHPAVTLVMLFVQGALSFAVGSTLISQVLYAADAAPTLGGSFATAAFNVGAALGPALGGLAIGMGLSYRAPLWTSAALVTLAIVIGAATLSLWRRPASVQETVPA	13.30	gnl|BL_ORD_ID|1599|hsp_num:0	1744			378	468	chloramphenicol
BGC0000795.1|S-layer_19 # 14649 # 16850 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=12bp;gc_cont=0.293	BGC0000795.1|S-layer_19 	14649	16850	+	Loose	350	27.7202	Enterococcus faecalis chloramphenicol acetyltransferase	28.16	3004458	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	ATGGGAAATAGATTTTTTCAAATAATTAATTTGAAATCATTTTTTGCCTATATAATAATCACGTTATTAAGTTTTTTGATGTTAGTATATATAATGGAGCTATGGGATGTTGATTTAAATGTTCCGCTTGTATATTTAGGTGATGGTTTATCAGCAGGAATGTTAGTGAAAAGCGTAATTGATAATGGTTGGTTTTTGGAAAATCAATATTTAGGAGCACCTATAGGTGCGAATTTATATGATTATCCATTATCTGACGGATTTCATTTTCTTTTAATGAAATTAATAGCCTTGTTTCACCCTGATTATGCATTTGTAATGAATTTTTATTTGATACTTACATTTCCGTTTACAGCTATAGTATCATTTTTTGTTTTTCGACAATTTAACATTTCTTATATTCCAGCCTTTGTTGGTAGTATGCTGTATACTTTTTTGCCATACCATTTTTTTCGGTGGGCAGGTGGGCATATCTTTTTGGCTGCATATTATACAGTACCATTGGTAGTTATGGTTTTTTTATGGATGTTTTGTGAGAAAAATTTTCTCTTTTTCTATAATGAGGACAAAGGCAAGTATAAGTTTGAGTTATTTAGTTTTAAATCCATGGTTAGTATAATTGCTTGTCTTTTAATCTCATCTAGTGGTATATATTATGCATTTTTTACGTGTTTTTTTCTTGCTGTTCAAGGTTTAGCTATATCTATTTTTAGGAAAAGATTTATACCTATAGTAGTTGCTGGTTTCTTAATATCTACGGTATGTATAGGAGTTTTGGCTAACGTAGTTCCTAATATAATTTATACACATTATAACGGGGAAAATAGCGAGGTTGGAAAACGAAGTCCATTAGAAGCCGATCTATATGGTTTGAAGATTTCACAATTGCTTCTTCCGATTTCTGGACATAGAATTAGTTTTCTTAAGGAGTTGAAGGAGAAATATAACAGTTCTTTTCCTTTGGTCAATGAGAACGATAATGCATCTTTGGGGATTTTAGGAAGTACTGGTTTTTTAATCTCTCTATATATTTTCTTATTTAGACGTGAGCAAAAAAATGATATTAAGCAAAATTTAAGTTTCCTTAATGTTTGTTCGATACTCTTTGCTTCAATAGGTGGTTTAAGTACGTTATTTTCAATTTTGATATCTCCTCAAATTAGGGGGTATAATCGTATAAGTGTATTTATAGCTTTTTTTTCTATTTTTATTTTGGTACTAGTATTTAACGACTTTAAAAAAAAGTTTATTAGTAATAGAGCTTTGAAAATAGTTTTTAATACTTTCTTGATAATAATTTGTCTAGTGGGAATTTTGGATCAAACAAATAAAAATTTTTTCTTACCCTATGAAATATTGGAAAAAGAATATAAAAATGATAAGGAGTTTATTCGAAAAATTGAAGTTTCCCTACCAAAAGGAGCAATGATTTTTCAAATGCCTTATGTTTCTTTTCCTGAACAGCCTCCTGTAAATCAAATGGGTGGATATGATTTGGCAAAAGGGTATTTACATTCTACCAACTTAAAATGGAACTTTGGAGCAACAACTGGAAGAGAAAGTGATGCATGGCAAAAGAATACCATAAATAAAACTTTGGATGAGATGATTGAAACATTATCTTTAGCAGGTTTTAAGGGAATATATATTGATCGGAACGGTTATGCGGATAAAGGGATTGAGATAGAAGGGAAACTCTCATCAATACTTAAAACTAAGCCGTTAATTAGTGAAAATCAAAGATTATCTTTTTTTAATATGGAGACGTATAATAAGGAAGTTGAAAATAAATACACAAAAAATGAATTGAATTTAAAAAGGGATAATGCTCTACATCTTGTTTTATTAACATGGAAAAATGGATTCTATGGTTTAGAGCAGAATGAAAGTGGTAGCTGGCGATGGAGTCAGGATAAGAGTTCGATGATAATTAATAATTATTCTTCAAAAGAGAGAATTGTTACTATCGAAATGTCTTTTCAAACAGGATATGAACAATTGTCTAGTTTGTTTATAGAAACCCCGACGTTTAAAGAAGAGTTAAAAGTAAATAATAAAGAAAAAAAATATATAAAAACAATACGGATTCCTTCGGGAAGTTACATTATTAAATTTACTAGCAATGCTGAGAAGGTTAATGTGCCTGATGAATCACGTAATTTATTTTTTAGAGTAAACAACTTTAAAATAGACTATAAATAA	MGNRFFQIINLKSFFAYIIITLLSFLMLVYIMELWDVDLNVPLVYLGDGLSAGMLVKSVIDNGWFLENQYLGAPIGANLYDYPLSDGFHFLLMKLIALFHPDYAFVMNFYLILTFPFTAIVSFFVFRQFNISYIPAFVGSMLYTFLPYHFFRWAGGHIFLAAYYTVPLVVMVFLWMFCEKNFLFFYNEDKGKYKFELFSFKSMVSIIACLLISSSGIYYAFFTCFFLAVQGLAISIFRKRFIPIVVAGFLISTVCIGVLANVVPNIIYTHYNGENSEVGKRSPLEADLYGLKISQLLLPISGHRISFLKELKEKYNSSFPLVNENDNASLGILGSTGFLISLYIFLFRREQKNDIKQNLSFLNVCSILFASIGGLSTLFSILISPQIRGYNRISVFIAFFSIFILVLVFNDFKKKFISNRALKIVFNTFLIIICLVGILDQTNKNFFLPYEILEKEYKNDKEFIRKIEVSLPKGAMIFQMPYVSFPEQPPVNQMGGYDLAKGYLHSTNLKWNFGATTGRESDAWQKNTINKTLDEMIETLSLAGFKGIYIDRNGYADKGIEIEGKLSSILKTKPLISENQRLSFFNMETYNKEVENKYTKNELNLKRDNALHLVLLTWKNGFYGLEQNESGSWRWSQDKSSMIINNYSSKERIVTIEMSFQTGYEQLSSLFIETPTFKEELKVNNKEKKYIKTIRIPSGSYIIKFTSNAEKVNVPDESRNLFFRVNNFKIDYK	MTFNIIELENWDRKEYFEHYFNQQTTYSITKEIDITLFKDMIKKKGYEIYPSLIYAIMEVVNKNKVFRTGINSENKLGYWDKLNPLYTVFNKQTEKFTNIWTESDKNFISFYNNYKNDLLEYKDKEEMFPKKPIPENTIPISMIPWIDFSSFNLNIGNNSSFLLPIITIGKFYSENNKIYIPVALQLHHSVCDGYHASLFMNEFQDIIHRVDDWI	340.93	gnl|BL_ORD_ID|2505|hsp_num:0	2897			297	606	chloramphenicol
BGC0000795.1|S-layer_20 # 16885 # 17304 # 1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=GAGG;rbs_spacer=7bp;gc_cont=0.345	BGC0000795.1|S-layer_20 	16885	17304	+	Loose	450	26.1794	aadA9	31.43	3002609	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(3'')	ATGGAAAATAAAGTTATTAACTTCAAGAAAATTATTGATTCTCGAGGTTCCCTAGTAGCTATTGAGGAAAATAAGAATATCCCATTTTCAATTAAGCGTGTGTATTACATTTTTGATACGAAGGGAGAAGAGCCAAGGGGATTTCATGCGCATAAAAAATTAGAGCAGGTACTTGTTTGCTTGAACGGGAGTTGCCGTGTTATTCTCGATGATGGAAATATAATACAGGAGATAACTCTTGATAGTCCTGCAGTTGGTCTTTATGTAGGACCTGCTGTTTGGCATGAAATGCATGATTTCTCAAGTGATTGTGTGATGATGGTATTAGCTAGTGATTATTACGATGAAACGGACTATATTCGGCAATATGATAACTTTAAAAAGTATATCGCTAAAATTAATCTAGAAAAAGAAGGATAA	MENKVINFKKIIDSRGSLVAIEENKNIPFSIKRVYYIFDTKGEEPRGFHAHKKLEQVLVCLNGSCRVILDDGNIIQEITLDSPAVGLYVGPAVWHEMHDFSSDCVMMVLASDYYDETDYIRQYDNFKKYIAKINLEKEG	MLWSSNDVTQQGSRPKTKLDMMSNSIHTGISRQLSQARDVIKRHLASTLKAIHLYGSAIDGGLKPYSDIDLLVTVDARLDEATRRSLMLDFLNISAPPCESSILRPLEVTVVACNEVVPWRYPARRELQFGEWLREDILEGVFEPAALDADLAILITKARQHSIALVGPVAQKVFMPVPEHDFLQVLSDTLKLWNTHEDWENEERNIVLTLARIWYSTETGGIVPKDVAAEWVLERLPAEHKPILVEARQAYLGLCKDSLALRADETSAFIGYAKSAVADLLEKRKSQTSHICDGAKNV	46.49	gnl|BL_ORD_ID|290|hsp_num:0	323			606	711	spectinomycin; streptomycin
BGC0000795.1|S-layer_21 # 17367 # 17945 # 1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=11bp;gc_cont=0.349	BGC0000795.1|S-layer_21 	17367	17945	+	Loose	400	46.9802	vatB	46.15	3002841	protein homolog model	n/a	n/a	streptogramin antibiotic; streptogramin A antibiotic	antibiotic inactivation	streptogramin vat acetyltransferase	ATGTCTAGTTCTAGTGAAACTTGTTTTGTTCACCCTAACGCAATTGTAGAGACCAAAAAGATAGGAAATAATACGAGAATATGGGCCTTTGTTCATATTCTTCCTCAGGCAATGATAGGGGATAATTGTAACATTTGCGATCATTGTTTTATTGAAAATGATGTGTTTATTGGGAATAATGTGACTGTGAAATCAGGTATCTATATTTGGGACGGAGTGTATATTGAAGATAATGTATTCTTAGGGCCTAATGTTGTATTTACTAATGATGTTTTCCCACGAAGTAAGGTGTATCCAGAATCGTTTGGGAGAACTATAGTTAAGAAGGGTGCCAGTATTGGTGCTAATAGTGTTATTGTTGCAGGGAATATTATAGGGGAGTACGCTATGGTTGGGGCAGGATCTGTTGTAACCCGTGATATTCCTGATTATGCATTGGCTTATGGTAATCCTGCAAGAATAAAGGGATATGTATGCCAATGTACTTCTAAATTAAAATTTATAGATAATCAAGCTGTATGCCAATGCGGAAAAAGATATAAATATGCTGATGGTATTGTTTCTCAATTAATTATTTAA	MSSSSETCFVHPNAIVETKKIGNNTRIWAFVHILPQAMIGDNCNICDHCFIENDVFIGNNVTVKSGIYIWDGVYIEDNVFLGPNVVFTNDVFPRSKVYPESFGRTIVKKGASIGANSVIVAGNIIGEYAMVGAGSVVTRDIPDYALAYGNPARIKGYVCQCTSKLKFIDNQAVCQCGKRYKYADGIVSQLII	MKYGPDPNSIYPHEEIKSVCFIKNTITNPNIIVGDYTYYSDVNGAEKFEEHVTHHYEFRGDKLVIGKFCAIAEGIEFIMNGANHRMNSITTYPFNIMGNGWEKATPSLEDLPFKGDTVVGNDVWIGQNVTVMPGIQIGDGAIVAANSVVTKDVPPYRIIGGNPSRIIKKRFEDELIDYLLQIKWWDWSAQKIFSNLETLCSSDLEKIKSIRD	90.57	gnl|BL_ORD_ID|1096|hsp_num:0	1189			342	498	virginiamycin M1; madumycin II; griseoviridin; dalfopristin
BGC0000795.1|S-layer_22 # 17961 # 19055 # 1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=6bp;gc_cont=0.354	BGC0000795.1|S-layer_22 	17961	19055	+	Loose	575	29.261	SPR-1	31.17	3006996	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	SPR beta-lactamase	ATGATGATTCCTTTTTTGGATTTAAGACAAATAAATATGAGATATCAAAAAGAGATTCAACAAGCAATGAATAGAGTGCTTGAATCGGGATGGTATATTTTAGGGGGAGAAGTGGATGATTTTGAAAGAAAGTTTGCCAGTTATTGTGGTGCAAAATATTGTATTGGGGTAGCAAATGGACTAGATGCTTTAACATTGATTATTAGAGCATATGATATAGGATTAGGAGATGAGGTAATAGTTCCTTCCAATACCTATATTGCTTCTATTCTTGCTATTTCAGCAAATGGTGCTACTCCTGTTTTGGTTGAACCAGATATAAATACATACAATATTGATCCCCTAAAAATTGAAGAGAAAATAACTTCGCGTACAAAAGCGATTATGGTTGTTCATTTATATGGACAATCATGCGATATGGAATCAATCAATTTGATAGCTAAAAAATATAATTTAAAAGTAATAGAAGATTGTGCACAAGCGCACGGAGCCATTTATAATGGAAAACGGGTAGGAAGTCTTGGAGATGCGGCTGGCTTTAGTTTTTATCCAGGGAAAAATTTAGGAGCATTAGGTGACGGTGGCGCGATCACAACAAACGATGCTGAACTAGCTGAACGCTTAAATGTTTTACGTAATTATGGTTCACATAAAAAGTATGAAAATCTTTTTAAAGGTGTTAATAGTCGCTTAGATGAATTACAAGCGGCGATCCTTAGTATAAAACTTTCTTACTTGGATGATGATAATCAAAGAAGACGGGAAATTGCAGCATATTATTTAGAACATATAAAGAATCCGTTTATTCATTTGCCAACTGTTACGGATGATAAGGCTCATGTTTGGCATTTATTTGTAGTTCGAGTAAAGGAAAGAGAAGCATTTCAGTACTATTTGGCAGAACAAAACATTCAAACCCTTATTCATTATCCGATTCCGCCACATAAACAAAAGGCTTATAGTGAGTGGCAGCAAGAAAGCTTTCCGATTTCTGAACAAATACATAGTGAGGTTGTTAGTTTGCCCATAAGCCCAGTTATGAGTAGAGAGGAAGTCGAAAGGGTTGTGGAGGCTGTTAACAGGTATGGATACTAG	MMIPFLDLRQINMRYQKEIQQAMNRVLESGWYILGGEVDDFERKFASYCGAKYCIGVANGLDALTLIIRAYDIGLGDEVIVPSNTYIASILAISANGATPVLVEPDINTYNIDPLKIEEKITSRTKAIMVVHLYGQSCDMESINLIAKKYNLKVIEDCAQAHGAIYNGKRVGSLGDAAGFSFYPGKNLGALGDGGAITTNDAELAERLNVLRNYGSHKKYENLFKGVNSRLDELQAAILSIKLSYLDDDNQRRREIAAYYLEHIKNPFIHLPTVTDDKAHVWHLFVVRVKEREAFQYYLAEQNIQTLIHYPIPPHKQKAYSEWQQESFPISEQIHSEVVSLPISPVMSREEVERVVEAVNRYGY	MKKNLGYLTAMTVALCFGAQAQLNPAQPLSSAPPYSLFEQWAQPVAPFQMFPHVYYVGTRNLSSVLLSTPEGLILIDAALDASAPAIRAHIEALGFNIKDLRYILNSHARLDQAGGIARLQVWSGAKVVASAANAQQLALGGKQDFALGDALSFPPVKVDIIVGEGDSITLGDLKLTALMTPGHLPGATSWLTTLHQGGQSYRLVYADSLATPDYYLIDNKNYPSLVQDIRGSFARLAQQQADIFIVNKGTRFDLDNKMQRLQAGDLDAFVDRQGLQQYVQQSQQTFEAQLKQQQSKM	122.15	gnl|BL_ORD_ID|4591|hsp_num:0	5661			378	603	
BGC0000795.1|S-layer_23 # 19045 # 19977 # 1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=12bp;gc_cont=0.343	BGC0000795.1|S-layer_23 	19045	19977	+	Loose	550	144.05	PmrF	28.62	3003578	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGGATACTAGAAAAAAGTTTTCTATTCTTGTTCCTATTTATTTTAATGAGCTCAATATCCCGTATACAGTACCAAGGTTGCAAAATTTGCAAAATATATTACCTGAGTATGACTTAGAATTTGTTTTTGTAGATGACGGTTCTCAGGATAATTCCTTATCTTTGCTTTTAGAGGCAAAAAAGAGTGACGAACGAATCAAAGTAATTAAACTTAGTAGAAATTTTGGTTCAATGTCTGCTATTTCTGCGGGACTTCATTACGTTACAGGAGATTGTGTAGGAATTATCGCTGCCGATTTGCAAGATCCACCAGAATTATTTGCAGAGATGATAAAAAGTTGGGAGTCGGGAAAGAAAATAGTTATGGCGACCCGTTCTGATCGGGAAGAGTCTTTTTCGCAAAAGTTGTTTTCAAACTCCTATTATTTCCTTATGGATAAGTTTGCAATAAAAAATTATCCGAAAGGAGGTTTTGATTTCGTTCTTCTGGATAAGCAAGTTGTGCAAGAATTGAATAACATAAACGAGAAGAATACGAATATCATGAGCCTTATATTCTGGCTAGGACATGAACAGGACTTTATTCCATATGTAAGGCAGAAGAGAGAATTAGGCAAATCCCGATGGACAATGTCGAAAAAAATAAAGCTATTTATTGATTCATTTGTTAGTTTTTCTTATGTTCCAATTCGCTTTATGTCATTAGTTGGTTTTTTTACGGCACTTCTTAGTTTTTTATATGGTATATTCGCTGTTTTTAATACATTGACGGGTAATATTACTGTCCCTGGTTGGACGTCGGTTATTGGCCTAATTACTTTTTTGCTAGGTTTAATCATGGTTATGTTAGGAATTATTGGGGAGTATTTGTGGCGGGTATTAGATGAAGCGCGAAATAGACCGCATTATATAATTGACGAAGTATATGAATAA	MDTRKKFSILVPIYFNELNIPYTVPRLQNLQNILPEYDLEFVFVDDGSQDNSLSLLLEAKKSDERIKVIKLSRNFGSMSAISAGLHYVTGDCVGIIAADLQDPPELFAEMIKSWESGKKIVMATRSDREESFSQKLFSNSYYFLMDKFAIKNYPKGGFDFVLLDKQVVQELNNINEKNTNIMSLIFWLGHEQDFIPYVRQKRELGKSRWTMSKKIKLFIDSFVSFSYVPIRFMSLVGFFTALLSFLYGIFAVFNTLTGNITVPGWTSVIGLITFLLGLIMVMLGIIGEYLWRVLDEARNRPHYIIDEVYE	MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVEASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHERSTFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLGSIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYTDVRARPRYFVQQVIRPSSKENE	96.27	gnl|BL_ORD_ID|1937|hsp_num:0	2014			21	939	polymyxin B
BGC0000795.1|S-layer_25 # 20360 # 21277 # 1 # ID=1_25;partial=00;start_type=TTG;rbs_motif=GAGG;rbs_spacer=4bp;gc_cont=0.358	BGC0000795.1|S-layer_25 	20360	21277	+	Loose	1900	30.4166	mexN	29.87	3003705	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	TTGAAAGGGATTATTCTCGCTGGTGGGAGCGGAACAAGGCTTTATCCATTAACACGTGCTATTTCTAAGCAACTGTTACCTGTGTATGATAAACCGATGATTTACTACCCTTTATCTGTACTTATGCTAGCGGGAATTCGTGATATTCTTGTTATATCTACCCCTGAAGACACACCGCGTTTTGAACAACTGTTAGGAGATGGAAGTGAGCTCGGTATTTCGCTTTCTTATGCAATTCAGCCTTCGCCTGATGGGCTAGCTGAAGCTTTTATTATAGGTGAAGATTTTATTGGACAAGATAATGTTGCACTTATTTTAGGAGATAATATATTTTATGGTCAAGGCTTCACTCCATTATTACAAAGAGCTGTAAATAGAAAAAAGGGTGCAACAATATTTGCTAATGTTGTGAAAGACCCGGAACGATTTGGTGTTGTCGAATTTGATGAAAATAATAAAGTTTTATCCATAGAAGAAAAACCTGTATATCCTAAATCTAATTTTGCTGTAACGGGACTTTATTTCTATGATAATGATGTTGTTAAAATTGCGAAACAAATCGAACCTTCTGCAAGAGGAGAATTAGAAATCACTGATGTAAACAAAATATATCTTGAAAGAGGAGATTTAAATGTTGAACTTTTAGGGCGTGGTTTTGCCTGGTTAGATACAGGAACACATGAATCTCTTCTTGAAGCTTCCCAATTTATACAAACAATAGAGAAAAGACAGGGGCTTAAAGTGGCTTGTTTAGAGGAAATTGCTTACTATAAGGGATATATAAATAAAGAGCAATTAATTAGATTGGCTGAACCATTAAAGAAAAACGAGTACGGAGCATATCTATTAGAACTCGCAGAAAAAGGCTCCCTACAAACCGGATCAATAAATACAAAGGAAGCGGTGCTTTATGGATAA	MKGIILAGGSGTRLYPLTRAISKQLLPVYDKPMIYYPLSVLMLAGIRDILVISTPEDTPRFEQLLGDGSELGISLSYAIQPSPDGLAEAFIIGEDFIGQDNVALILGDNIFYGQGFTPLLQRAVNRKKGATIFANVVKDPERFGVVEFDENNKVLSIEEKPVYPKSNFAVTGLYFYDNDVVKIAKQIEPSARGELEITDVNKIYLERGDLNVELLGRGFAWLDTGTHESLLEASQFIQTIEKRQGLKVACLEEIAYYKGYINKEQLIRLAEPLKKNEYGAYLLELAEKGSLQTGSINTKEAVLYG	MTPRAGISGWCVRHPIATALLTLASLLLGLLAFLRLGVAPLPEADFPTIQINALLPGGSPETMASSVATPLEVQFSAIPGITEMTSSSALGTTTLTLQFSLDKSIDVAAQEVQAAINAAAGRLPVDMPNLPTWRKVNPADSPIMILRVNSEMMPLIELSDYAETILARQLSQVNGVGQIFVVGQQRPAIRIQAQPEKLAAYQLTLADLRQSLQSASVNLAKGALYGEGRVSTLAANDQLFNASDYDDLVVAYRQGAPVFLKDVARIVSAPEDDYVQAWPNGVPGVALVILRQPGANIVDTADAIQAALPRLREMLPATIEVDVLNDRTRTIRSSLHEVELTLLLTIGLVVLVMGLFLRQLSATLIVATVLAVSLSASFAAMYVLGFTLNNLTLVALIIAVGFIVDDAIVVVENIHRHLEAGASKVEAALKGAAEIGFTVISISFSLIAAFIPLLFMGGIVGRLFREFAVSVTVAILISVVASLTLAPMLASRFMPALRHAEAPRKGFAEWLTGGYERGLRWALGHQRLMLVGFAFTVLVAVAGYVGIPKGFFPLQDTAFVIGTSQAAEDISYDDMVAKHRQLAEIIASDPAVQSYNHAVGVTGGSQSLANGRFWIVLKDRGERDVSVGEFIDRLRPQLAKVPGIMLYLRAAQDINLSSGPSRTQYQYALRSSDSTQLALWAQRLTERLKQVPGLMDVSNDLQVGASVTALDIDRVAAARFGLSAEDVSQTLYDAFGQRQVGEYQTEVNQYKVVLELDARQRGRAESLDWFYLRSPLSGEMVPLSAIAKVAAPRSGPLQINHNGMFPAVNLSFNLAAGVSLGEAVQAVQRAQEEIGMPSTIIGVFQGAAQAFQSSLASQPLLILAALIAVYIILGVLYESFVHPLTILSTLPSAGIGAVFLLWAWGQDFSIMALIGIVLLIGIVKKNGILMVDFAIVAQREQGMSAEQAIYQACLTRFRPIMMTTLAALLGAIPLMIGFGTGSELRQPLGIAVVGGLLVSQVLTLFSTPVVYLALERLFHRRGTTTSDGGTAGATAT	29.44	gnl|BL_ORD_ID|2021|hsp_num:0	2217			462	678	chloramphenicol; thiamphenicol
BGC0000795.1|S-layer_26 # 21270 # 22301 # 1 # ID=1_26;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=12bp;gc_cont=0.336	BGC0000795.1|S-layer_26 	21270	22301	+	Loose	500	28.1054	cfrC	32.69	3004146	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; oxazolidinone antibiotic; phenicol antibiotic	antibiotic target alteration	Cfr 23S ribosomal RNA methyltransferase	ATGGATAAAGAAGAAAAGATAAATTCGATTCTTGTTACAGGTGGAGCCGGATTTATAGGCTCAAATTTTATCCCTTATTTTCTAGAAAAATATAATAATTACAGAATAATAAACTTAGATGCTTTGACATATGCAGGAAGTTTAAACAACCTTCAAGAAGTTGAACATCATCCAAGATATAAATTTGTAAAAGGTGATATTAATAACCGTCAATTATTAGAATATCTTTTTGAACAATTTAATATAAAAGGTGTTATTCACTTTGCCGCAGAGTCACATGTTGATAATTCAATTAAAGGGCCAGACATTTTTATTGAAACGAATGTGAAAGGCACATTTACATTATTGGAGACTGCGCGTAAATTTTGGATGATTGCTCCTTTTAAGTATCGAGAAGGATATGAACAATGCCGCTTTCACCATATTTCAACAGATGAGGTATATGGGACATTAGGAGAAGAAGGTTATTTTACGGAAGAAACACCTTATGCCCCTAATAGTCCATATAGTTCTAGCAAGGCTAGCTCGGATATGATAGTACGTAGTTATTTTCATACATATGGGTTGAATGTAGTAACTACAAATTGTTCTAATAATTATGGTCCAAAGCAGCATGATGAAAAATTAATCCCAACTGTTATTAGGAAAGCACTTGCGAATGAGCATATTCCGATCTATGGAGATGGGAAGAATGTACGTGATTGGCTATATGTACTAGATCATTGTCAAGCTATTGATGCAGTTTATCATCGAGGAGTATGTGGTGAGGTTTATAATATCGGTTCTAGAAACGAGCAAAATAATTTACAGATTGCTCATATGATTTGTGAATTGCTAGATAGGATGAAACCTATAGCAAAAGGAAGGAGTTATAAGGAATTAATAACTCTTGTACAAGATCGCCCTGGGCATGATCGTAGGTATGCGATTGACCCTAAAAAAATTGAAACTCAATTAGGCTGGAAAGCAGAAGAAAATTTTGAAGATGGGATTAGAAAAACGGTTCAGTGGTACTTAAACAAATATGAATAA	MDKEEKINSILVTGGAGFIGSNFIPYFLEKYNNYRIINLDALTYAGSLNNLQEVEHHPRYKFVKGDINNRQLLEYLFEQFNIKGVIHFAAESHVDNSIKGPDIFIETNVKGTFTLLETARKFWMIAPFKYREGYEQCRFHHISTDEVYGTLGEEGYFTEETPYAPNSPYSSSKASSDMIVRSYFHTYGLNVVTTNCSNNYGPKQHDEKLIPTVIRKALANEHIPIYGDGKNVRDWLYVLDHCQAIDAVYHRGVCGEVYNIGSRNEQNNLQIAHMICELLDRMKPIAKGRSYKELITLVQDRPGHDRRYAIDPKKIETQLGWKAEENFEDGIRKTVQWYLNKYE	MKQTKTKYGKMKQIASNLKLPDYRYEQLTKAIFHQRIDNFHDMHILPKALRIALVNEFGKNVSSVTPIFSQDSKQAQKLLFELTDGERIEAVGLKYKQGWESFCISSQCGCSFGCRFCATGSAGFKRNLTADEITDQLLYFYFNDHRLNSISFMGMGEAFANPELFDAVKILTDQNLFGLSQRRITISTIGIIPGIQRLTKEFPQVNLAFSLHSPFESQRSDLMPINKRFPLNEVMKTLDEHIIHTGRRVFIAYIMLEGINDSKEHAEAIIGLLRNRGSWEHLYHIDLIPYNSTDKTTFKFQSSSAIKQFCSTLKKASISATVRTQFGSEISAACGQLCYENEL	99.71	gnl|BL_ORD_ID|2412|hsp_num:0	2800			120	276	chloramphenicol; florfenicol
BGC0000795.1|S-layer_27 # 22500 # 22898 # -1 # ID=1_27;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.471	BGC0000795.1|S-layer_27 	22500	22898	-	Loose	700	26.9498	ACT-19	31.82	3001840	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	ACT beta-lactamase	ATGGATGAAGAAATCGCTCATCTTCTGTTTCAGGACGAGTGCATGATTCGTGATTATCAGGCAGTGCAGTACACCTGGTTTCTGCGCGGAAAGCAGCGCATCATTCCGACTTATGGCAAGCATCACGGAGTTAAGCTCATTGGCGTACTGAACTATGAAACAGGCCGCGTACACTGCGTAGAAGAGGAACAATACGATGCAGAAGCTTTTCTGCGTTTTCTTCAGCATGTGCCGAAACAGTACCCGACAGGCAAGATTGTCATGGTGTTAGACAATGCCCGCATTCATCATGCCCGTCTCATTCAGCCTTTTTTAGAAGAAAATCAGAACCGGCTAGAGCTTGTATTCTTGCCGCCATACAGCCCGGAAATGAACTTGATTGAAGGATTGTGGAAATAG	MDEEIAHLLFQDECMIRDYQAVQYTWFLRGKQRIIPTYGKHHGVKLIGVLNYETGRVHCVEEEQYDAEAFLRFLQHVPKQYPTGKIVMVLDNARIHHARLIQPFLEENQNRLELVFLPPYSPEMNLIEGLWK	MMKKSFCCALLLAISGSALAAPVSEKQLAEVVANTVTPLMKTQAIPGMAVAVIYQGKPHYYTFGEADIAAKKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTKFWPELTGKQWQGIRMLDLATYTAGGLPLQVPEEVTDNASLLRFYQHWQPQWKPGTTRLYANASIGLFGALAVKPSGMRYEQAMTKRVFKPLRLNHTWINVPKAEAAHYAWGYRDGKAVHISPGMLDAEAYGVKTNVQDMANWVMANMAPENIADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEAKMVIEGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANKSYPNPARVEAAYHILDALQ	34.65	gnl|BL_ORD_ID|214|hsp_num:0	236			363	495	
BGC0000795.1|S-layer_28 # 22891 # 23409 # -1 # ID=1_28;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.474	BGC0000795.1|S-layer_28 	22891	23409	-	Loose	1000	28.1054	MCR-2.3	50.0	3007284	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	ATGAATATTCATCCAACAGAACTGCAAACTGTACAACAAGCGATGAAACAGACAAAAGACAAGCGAATGTATGAACGCTACCAAGCCATCTCTTTATTTCTGCAGGGATACAAATATGAGCAAATCAGTGCCATCATTGGCCGGAATAAAAAAACGGTGGGCACATATGTCAAAGCCTACCGGGAACAAGGCTTAGAGGGGCTCGTGCGCCATGCATCGCCCGGTGCGCCTCACAAACTGACACCAGAACAAGAACAGGAACTGGTAGACATCATCGTCAATCATCTTCCGGTAGATGTAGGATTTGAAGCCCGCTACAACTGGACATTGGCTCTTATTGTGGCACTTGTCGAACAGAAATGGCAGAAAACCTACACCTTACGTGGCATGTCGCGTCTGCTCGGAAGCCTTGGCCTGAGCTACACCAAGCCAACGTATACTCTTGCCCAAGCAGACCCTGAGAAGCAAAGGGGGTTCCGGGAAGAAACATTTCCTGCTTTAAAAAAAACTGATGGATGA	MNIHPTELQTVQQAMKQTKDKRMYERYQAISLFLQGYKYEQISAIIGRNKKTVGTYVKAYREQGLEGLVRHASPGAPHKLTPEQEQELVDIIVNHLPVDVGFEARYNWTLALIVALVEQKWQKTYTLRGMSRLLGSLGLSYTKPTYTLAQADPEKQRGFREETFPALKKTDG	MTSHHSWYRYSINPFVLMGLVALFLAATANLTFFEKAMAVYPVSDNLGFIISMAVAVMGAMLLIVVLLSYRYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNAMQTDQAESKDLMNLAFFVRIIGLGVLPSLLVAVAKVGYPTWGKSLIQRAMTWGVSLVLLLVPIGLFSSQYASFFRVHKPVRFYINPITPIYSVGKLASIEYKKATAPTDTIYHAKDAVQTTKPSERKPRLVVFVVGETARADHVQFNGYSRETFPQLAKVDGLANFSQVTSCGTSTAYSVPCMFSYLGQDDYDVDTAKYQENVLDTLDRLGVGILWRDNNSDSKGVMDKLPATQYFDYKSATNNTICNTNPYNECRDVGMLVGLDDYVSANNGKDMLIMLHQMGNHGPAYFKRYDEQFTKFTPVCEGNELAKCEHQSLINAYDNALLATDDFIAKSIDWLKTHEANYDVAMLYVSDHGESLGENGVYLHGMPNAFAPKEQRAVPVFFWSNNTTFKPTASDTALTHDAITPTLLKLFDVTADKVKDRTAFIQ	31.97	gnl|BL_ORD_ID|4896|hsp_num:0	5889			735	807	colistin A; colistin B
BGC0000795.1|S-layer_29 # 23528 # 24922 # 1 # ID=1_29;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=12bp;gc_cont=0.401	BGC0000795.1|S-layer_29 	23528	24922	+	Loose	500	28.1054	OXA-731	29.58	3005936	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGAAACTCATTTTACTTTCCGGTGGCTCGGGTAAACGATTATGGCCATTATCTAACGATTCGCGATCTAAACAATTCTTAAAAGTACTCAAAAATGATAACAATGAATTTGAATCCATGGTACAACGAGTATGGAACCAGCTTCATACAGTTGGTTTAGCAGAAGACTCTTACGTTGCCACTAGCAAATCACAAGTAGACATGCTGCATGCCCAATTAGGAACTGAAGTTCCTCTTATTATCGAACCCGAACGTAGAGATACATTCCCAGCAATCGCTTTAGCAGCCACATATCTATACTCCATGGAAGGAGTACGAGAGGATGATGTGATTTCTGTTCTTCCTGTTGATCCATATGTGGAATCGCGTTTTTTTGATCGGGTTAAAGATTTGGAAACAGCACTTGTACAATCATCTGCAGAGTTAGCGTTAATAGGGGTAAAACCAACCTTCCCTTCTGAAAAATATGGCTACATTGTCCCCAAAAAAGGTGAACATGATGTTGTAGCGAATGTATTAGCTGTTGATTATTTCGTTGAAAAGCCAAGTACAAGCCGTGCGCAAGAACTTATGAAGCAGCAAGCATTCTGGAACTGCGGAATTTTCGCATTTAAGTTGGGATACCTTATTTCTCTTTTAAAAGAAAAAAAATTACCAACTGATTATGAAGAAATGCTTCATACATATAACCAGTTGCCTAAGATCAGCTTTGATTACGAAGTGGTAGAAAAGGCTCAAAATATTATTATGCTTCCATACGAAGGCGAATGGAAAGACCTTGGAACATGGAATACACTAACCGAAGAGATGAATACGAATCTTCTGGGAAAAGGTATCATTAGCGAGGGGTGTGAAAACACGCATCTGATTAACGAACTCGATATTCCAGTTACCATTCTAGGAATATCTAATGCGGTGATTGCAGCCAGCCCGGACGGTATTCTTGTTACGGATAAAGAAGCCAGTCCCCGAATCAAAGATATTATGAAAAACTTTAATCAGCGCCCAATGTATGAAGAGCGGCGCTGGGGATGGTACCGTGTACTGGATCATACGAAAGTAGAGAATGGAAATGAAGTTTTAACGAAACGCATCGGGGTTCATGCCGGGAAAAACTTAAGTTACCAAATTCATCATAAGCGGAGTGAAGTATGGACGATTATTTCCGGTGAAGGACAATTTGTTTTAAACGATCAATTATATCATGTAAAACCGGGAGACGTCTTGCAGATTCCTGTGGGTGCTAAACATGCCATTCGTGCTATTACCGATTTACAGTTTGTCGAAGTACAAACAGGCAGTGAATTGATCGAGGAAGATATTATTCGCCTGTGTATGACATGGGAAGAAACGCTAGACTGTTGCAAGGATTGCATAGTAAAAGTTATTCGCTGA	MKLILLSGGSGKRLWPLSNDSRSKQFLKVLKNDNNEFESMVQRVWNQLHTVGLAEDSYVATSKSQVDMLHAQLGTEVPLIIEPERRDTFPAIALAATYLYSMEGVREDDVISVLPVDPYVESRFFDRVKDLETALVQSSAELALIGVKPTFPSEKYGYIVPKKGEHDVVANVLAVDYFVEKPSTSRAQELMKQQAFWNCGIFAFKLGYLISLLKEKKLPTDYEEMLHTYNQLPKISFDYEVVEKAQNIIMLPYEGEWKDLGTWNTLTEEMNTNLLGKGIISEGCENTHLINELDIPVTILGISNAVIAASPDGILVTDKEASPRIKDIMKNFNQRPMYEERRWGWYRVLDHTKVENGNEVLTKRIGVHAGKNLSYQIHHKRSEVWTIISGEGQFVLNDQLYHVKPGDVLQIPVGAKHAIRAITDLQFVEVQTGSELIEEDIIRLCMTWEETLDCCKDCIVKVIR	MRALALSAVLLVASIIGMPAEAKEWKETQSWNTHFTEHKTQGVVVLWNENKQQGYTNDLKRANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIAAWNRDHDLITAMKYSVVPVYQEFARKIGQARMNKMLHAFDYGNEDISGNLDSFWLDGGIRISAIQQIEFLRKLYHNKLHVSERSQRIVKQAMLTEANADYIIRAKTGYSVRIEPKIGWWVGWVELDDNVWFFATNMDMPTSDGLGLRQTITKEVLKQEKIIP	175.09	gnl|BL_ORD_ID|3971|hsp_num:0	5041			39	240	cloxacillin; oxacillin; cefalotin
BGC0000795.1|S-layer_30 # 24939 # 26108 # 1 # ID=1_30;partial=00;start_type=TTG;rbs_motif=GAGG;rbs_spacer=4bp;gc_cont=0.403	BGC0000795.1|S-layer_30 	24939	26108	+	Loose	700	43.5134	LpsB	23.48	3005051	protein homolog model	n/a	n/a	peptide antibiotic	reduced permeability to antibiotic	Intrinsic peptide antibiotic resistant Lps	TTGGGAGATAATCTTCAAGGGCCTGTTTTTTTAGGAGGGATTATCATAAAGGTTTTATTTGAGTCACAGCCTTTATTAGGACGACGCACCGGCATTGGGCGTTATGTAGAGAGACTAACGGCCAGCCTGCAGGAGAATCAGGATATTGATTTGTTTTATTGGTTTAATCAACAGTTCAATGTAAAATTATTGCAAATGTTAGATGTTCCGTCGACTAAGATCAGAAATTCCCGGTATTTCTATAAGGTGATTCGGCGTTTAATGAAGCCTAACTTTTTGCATGACTTGCCTGTCGACTTAGGGGAATCGTTCGATATTTTTCATGGAGGTAGTTGTATTACTTATCAAACCACAAAGGCAAAAAATGCACTTACCATTCATGACTTAGCTTTTCTTCAGTTTCCAGAGGTGGCCAGTGAGCAGACGGATCGCCATCACTCCTTATGGCTCCCTTATTCAATAAAAAAGGCAGACCATATTATTGCTGTATCACAGCATACTAAAGAGGATATTATTCGCTATTATGATGTACCTGACGAAAAAATCAGCGTCATTTATTTGGCGGCAGACGACCAGATTAAAAAAGAGGACAGGCCTTTAAAGGAAGAAGTACAAGCGAAATATAATTTACCGGAAAAATACGCGTTGTATGTAGGGACAATTGAGCCAAGAAAGAACATCCCATTTATGCTGGAAGGATATGCTCTTGCTAAACAAAAATATAAATTTCCTCATAAGCTTGTGATTGCTGGGGCGAAAGGGTGGAAGTACGAAAAAGTATATGAGACGTTTGAAAAATATCGGTTGCATAACGATGTAATTTTTACTGGTTATGTGGAAGATATGGACTTACCTGTTCTGTATGAGAATGCGGATGTGTTCCTGTTTCCATCACGATACGAAGGATTTGGTATTCCCGTATTGGAAGCCATGCAATGTGGGGTAGCCGTTATTGCTTCTAATGTATCTTCTCTTCCTGAAATTGTAGGAGAAGCGGGGAGATTGGTATCACTGGAGAAACCGGAAGAATTTATCGATAGTATTGGTGAGCTATTGACAAATGAGGCGAAAAGAAGAGAATACGAAGAAGCGGGCAGACGACAAGCCCGGATGTTTAGCTGGAAAAAAGCCGCTTCCGAAACGGTTACTGTCTATCGGAGCTTATTGTAA	MGDNLQGPVFLGGIIIKVLFESQPLLGRRTGIGRYVERLTASLQENQDIDLFYWFNQQFNVKLLQMLDVPSTKIRNSRYFYKVIRRLMKPNFLHDLPVDLGESFDIFHGGSCITYQTTKAKNALTIHDLAFLQFPEVASEQTDRHHSLWLPYSIKKADHIIAVSQHTKEDIIRYYDVPDEKISVIYLAADDQIKKEDRPLKEEVQAKYNLPEKYALYVGTIEPRKNIPFMLEGYALAKQKYKFPHKLVIAGAKGWKYEKVYETFEKYRLHNDVIFTGYVEDMDLPVLYENADVFLFPSRYEGFGIPVLEAMQCGVAVIASNVSSLPEIVGEAGRLVSLEKPEEFIDSIGELLTNEAKRREYEEAGRRQARMFSWKKAASETVTVYRSLL	MKVMQLLPELNSGGVERGTLEIARALVAQGHQSLVVSNGGRLVSQLEAEGSTHLTLPIHKKSLSSLWQIRPLRQLIEEHQPDIVHVRSRVPAWLTHFALRKIPANKRPHLISTVHGFYSVNRYSAIMTQAEKVIAVSDSVVKYITGHYKNCPPQDIIRIYRGIDPAAFPHNYQPSAQWFNQVFNDFPELENKFLLCLPGRITRLKGHESLIELMQQLHSQYPQLHAVVVGGADVKKQAYLSELQNTIQSKGLADKITFVGHRSDIREWLAFSDIVLSLSNQAETFGRTALEALSVGTPVIGWNRGGVAEILSHVYPQGLVEAENEKALLEIVKHHIEQPQTVAPVTMFSLKDMCDQTLELYQSVLK	106.28	gnl|BL_ORD_ID|2781|hsp_num:0	3793			378	1095	colistin A; colistin B; defensin
BGC0000795.1|S-layer_31 # 26137 # 27270 # 1 # ID=1_31;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.380	BGC0000795.1|S-layer_31 	26137	27270	+	Loose	700	52.7582	LpsB	22.76	3005051	protein homolog model	n/a	n/a	peptide antibiotic	reduced permeability to antibiotic	Intrinsic peptide antibiotic resistant Lps	ATGAAAATATTACAAGTAAATAAATTTTATCCCCCGGTCATTGGAGGGGTTGAAAAAGTTGTATATGATTTGGTAGAAGGAATGTGTTCACTTGCGGAAATGGAGGTGCTTGTTGCTAATACTGAATGGAAATATGTACAGGAAATCGAACATAAGGCAAAGATACATAGGGTTCCGAGTATTGGCACTTACTTTTCCATGCCGGTAGCTCCTACGTTTCCGCTTTGGCTTAAAAAAATTAAGACCGATATTATACATTTTCACTTTCCTTTTCCGTTAGGAAAGTTGTCTTATTTGCTTGTAGACAAGATAGCAAATATACCGGCGAAAACAGTCGTAACATGGCATAGTGATATCGTTAGGCAAAAGCGTTTTTTGAAGCTTTATCACCCTTTTCTAAAGAGATTTCTTGAAAAAGTGGACACAATCATTGCGACTTCACCGAATATGGTTGAGGCCTCTCCATACTTAAAAGAGCATAAAGATAAATGTCGGGTAATTCCGCTTGGAATTGATGTTAAAGAATGGGAAAAAACAGACAAGCTTTTTGAGAATGTGAAAAAGGTAAGAGAAGAGGTGGCTATAAAGCCTATTATTTTGTTTGTAGGACGTCTTGTTTATTACAAGGGTGTCGAATATTTAATTGAGGCGATGACAGAGATAAATGCCTCCCTTTTTCTTGTTGGCGAATGGCCTTTAAAACCGTTATTACAAAAAAGAGCTGAGGAACTAGGAATTACGGAAAAAATAAACTTCTTGGGAGGGGCAAGCAAAGAGCAATTAGTGACATATCTGCATGCTTGTGACATTTTCGTTTTACCTTCTGTAGAGCGAAGTGAGGCTTTTGGGATTGTCCAACTTGAAGCCATGGCGTGCGGAAAGCCTATAGTAAGCACAAATTTAGCTACAGGTGTGCCATTTGTAAATCAGGATGGAAAAACGGGAATTGTAGTACCACCAAAAGATATAAAATCCTTGACACAAGCTCTTACTTTCTTAATTGAAAATGAATCTGTTCGAAAGCAATATGGTGAACGAGGGAAAGAAAGGGTTTATGAGCATTTCACACGAGAGAAAATGGTACAAAGTGTATATACGTTGTACCAGGAACTCCTGGAAGGTGGAACAACATAA	MKILQVNKFYPPVIGGVEKVVYDLVEGMCSLAEMEVLVANTEWKYVQEIEHKAKIHRVPSIGTYFSMPVAPTFPLWLKKIKTDIIHFHFPFPLGKLSYLLVDKIANIPAKTVVTWHSDIVRQKRFLKLYHPFLKRFLEKVDTIIATSPNMVEASPYLKEHKDKCRVIPLGIDVKEWEKTDKLFENVKKVREEVAIKPIILFVGRLVYYKGVEYLIEAMTEINASLFLVGEWPLKPLLQKRAEELGITEKINFLGGASKEQLVTYLHACDIFVLPSVERSEAFGIVQLEAMACGKPIVSTNLATGVPFVNQDGKTGIVVPPKDIKSLTQALTFLIENESVRKQYGERGKERVYEHFTREKMVQSVYTLYQELLEGGTT	MKVMQLLPELNSGGVERGTLEIARALVAQGHQSLVVSNGGRLVSQLEAEGSTHLTLPIHKKSLSSLWQIRPLRQLIEEHQPDIVHVRSRVPAWLTHFALRKIPANKRPHLISTVHGFYSVNRYSAIMTQAEKVIAVSDSVVKYITGHYKNCPPQDIIRIYRGIDPAAFPHNYQPSAQWFNQVFNDFPELENKFLLCLPGRITRLKGHESLIELMQQLHSQYPQLHAVVVGGADVKKQAYLSELQNTIQSKGLADKITFVGHRSDIREWLAFSDIVLSLSNQAETFGRTALEALSVGTPVIGWNRGGVAEILSHVYPQGLVEAENEKALLEIVKHHIEQPQTVAPVTMFSLKDMCDQTLELYQSVLK	103.01	gnl|BL_ORD_ID|2781|hsp_num:0	3793			36	909	colistin A; colistin B; defensin
BGC0000795.1|S-layer_32 # 27270 # 27605 # 1 # ID=1_32;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=12bp;gc_cont=0.482	BGC0000795.1|S-layer_32 	27270	27605	+	Loose	400	32.3426	IMP-15	34.48	3002206	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	IMP beta-lactamase	ATGGGAGATATTTATGTAAATGCTCGTTTCATGAATCAAGTTGTTACCGGAGTACAACGGTATGCTTGGGAGATTACTAATCATTTACGGGATAGAGTTCATATCATACAGCCGGGCAAGAGCTTTTCCGGAGAAGCAGGTCATTTTTGGGAGCAGATTGTACTTCCGGGCAGAATGCCGCGGAATGCTCTGCTTTGGTCGCCAGCGGGGGCGGGGCCTTTATTAGTATCTAAGCAAGTTGTAACGCTCCATGATATTGCCCATCTTGAACACCTCACCATCCTCGTGGTTTTGCAGTGTTTCTCTTCACGGCAGGTCTCCTGGCTTCGGGTCTGA	MGDIYVNARFMNQVVTGVQRYAWEITNHLRDRVHIIQPGKSFSGEAGHFWEQIVLPGRMPRNALLWSPAGAGPLLVSKQVVTLHDIAHLEHLTILVVLQCFSSRQVSWLRV	MNKLSVFFMFMFCSITAAGESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNTEAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASELTNELLKKDGKVQAKNSFSGGSYWLVNNKIEVFYPGPGHTPDNVVVWLPENRVLFGGCFVKPYGLGNLGDANLEAWPKSAKILMSKYGKAKLVVSSHSETGNASLLKLTWEQAVKGLKESKKPSLPSN	45.12	gnl|BL_ORD_ID|1332|hsp_num:0	1456			333	501	
BGC0000795.1|S-layer_33 # 28033 # 28236 # -1 # ID=1_33;partial=00;start_type=ATG;rbs_motif=GAGG;rbs_spacer=7bp;gc_cont=0.441	BGC0000795.1|S-layer_33 	28033	28236	-	Loose	700	21.557	oleI	53.33	3000866	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGGCTATGTATGATAGGAAGCAACCCTATGTAATCCAAGAGAAACCCGGAAAAAAAGCTTATTGTGCTTGTGGTTTGACTGGGAACCCTCCGTATTGTGATGGCTCTCACAAAGGGACAGGAAAACAGCCGTTCATTGTGAATATTGAAGAACCGAAAACAGTCGCGATTTGCGGGTGCGGAAAATCCGGGAATTTACCGTAA	MAMYDRKQPYVIQEKPGKKAYCACGLTGNPPYCDGSHKGTGKQPFIVNIEEPKTVAICGCGKSGNLP	MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGATPVVYDSILPKESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASWPAPVLGRKWDIPFVQLSPTFVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVALPRTFQIKGDTVGDNYTFVGPTYGDRSHQGTWEGPGDGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADLGEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERIVELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGILAEAG	15.80	gnl|BL_ORD_ID|1684|hsp_num:0	1824			708	753	oleandomycin
BGC0000795.1|S-layer_34 # 28575 # 28757 # 1 # ID=1_34;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.421	BGC0000795.1|S-layer_34 	28575	28757	+	Loose	1700	21.9422	AxyY	33.33	3004144	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGATAAGGAGCGGATTATGTTATGAAAAAATCACTGATTACAAACTTACGAATGAAGCATTACGAAAGGAAGAGCGTGCGATTTCTGATGCTTTTTTCCGGCAGCGTGTGACGGCCGTTCGACTGATTCTTGAAGGTTTTTCTACGGTAAAAGCTGCAGAAGTACTGGGCATTTGTCACTAG	MIRSGLCYEKITDYKLTNEALRKEERAISDAFFRQRVTAVRLILEGFSTVKAAEVLGICH	MARFFIDRPVFAWVISLLIALVGLLSIRALPVAQYPDIAPPVVNIGASYPGASAKVVEEAVTAIIEREMNGAPGLMYTSSSSDSTGWASINLTFKQGTNPDIAAVEVQNRLKAVEPRLPESVRRDGVRVEKAADNIQLVVSLKSDGSLDDMQLGELAASNVLQALRRVEGVGKVQSFGAEAAMRIWPDPAKLTALSLTPGDIVSALRSHNARVTIGELGNQAVPKDAPLNASIVAGESLHTPEQFANIPLRALPDGATLRLKDVARVELGGTDYMYLSRVNGLTGTGLGIKLAPGSNAVETTRRIRETMRELAQYFPPGVTWDIPYETSTFVEISIKKVLMTLLEAVALVFCVMYLFMQNLRATLIPTLVVPVALLGTLGVMLGLGYSINVLTMFGMVLAIGILVDDAIVVVENVERIMAEEGLSPHDATVKAMGQISGAIVGITVVLVSVFVPMAFFDGAVGNIYRQFAVTLAVSIAFSAFLALSLTPALCASLLKPVPAGHHEKRGFFGWFNRAFARLTTRYTARVAGVLARPVRFGLAYALVIGVAALLFARLPSSFLPDEDQGSFMAMVILPQGSPQAETMAVVKDVERYMMEHEPVQYVYSVNGFSQYGSGPNSAMFFVTLKDWKERRDASQHVDAVVKRINKAFADRKNLMVFALNSPPLPDLGSTSGFDFRLQDRGGLGYEALTQARQKLLAKAAEHPALTDVVFAGQEEAPQLQLRVDRDKAQAMGVPIDEINTALAVMYGSDYIGDFMLNGQVRRVMVQADGKRRVDVDDISRLHVRNLQGQMVPLSAFATLTWSMGPPQLNRYNGFPSFTINGSAARGHSSGEAMRAMETLAAELPRGIGFDWSGQSYEERLSGNQAPVLFALSVLIVFLALAALYESWSIPLAVILVVPLGVIGALLGVTVRGMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVRDGQGILSATLEAARLRLRPIVMTSLAFGVGVLPLALATGAASGAQAAIGTGVLGGIITATVLAVFLVPLFFLIVGRMVGMRARPARPDGREPLETTP	5.74	gnl|BL_ORD_ID|2411|hsp_num:0	2799			2043	2169	erythromycin; cefepime
BGC0000795.1|S-layer_36 # 29305 # 29460 # -1 # ID=1_36;partial=00;start_type=TTG;rbs_motif=GAG;rbs_spacer=10bp;gc_cont=0.449	BGC0000795.1|S-layer_36 	29305	29460	-	Loose	400	22.3274	IMP-88	58.33	3005491	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	IMP beta-lactamase	TTGGCCGCAACAGGAAACGGCAATATCCCCTTACCCGAAGACCTTCAGAAGCTTATCGATACAGGCAAACGGGAAGTACATACAGAAAACGGTCAGCTTGTCCTAAAGAATTCGAAACCTGACTACGTATTCACATGGATGCCAGAACAAAAATAA	MAATGNGNIPLPEDLQKLIDTGKREVHTENGQLVLKNSKPDYVFTWMPEQK	MSKLSVFFIFLFCSIATAAESLPDLKIEKLDEGVYVHTSFEEVNGWGVFPKHGLVVLVNAEAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSRSIPTYASELTNELLKKHGKVQATNSFSGVNYWLVKNKIEVFYPGPGHTPDNVVVWLPERKILFGGCFIKPYGLGNLGDANIEAWPKSAKLLKSKYGKAKLVVPSHSEVGDASLLKLTLEQAVKGLNESKKPSKPSN	20.73	gnl|BL_ORD_ID|3642|hsp_num:0	4711			474	510	
BGC0000795.1|S-layer_37 # 29786 # 30061 # 1 # ID=1_37;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=11bp;gc_cont=0.380	BGC0000795.1|S-layer_37 	29786	30061	+	Loose	500	23.8682	mefJ	47.06	3007049	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGTACTGGTATCATGATCCAAATTATGTGCAGCAGTATAGTCCGGACATACAACAATATGATTACTACGTTTATCCTGACCTTGAGAGACAACCACAACTATTTGGGAGAGTTAATCAACTTGAAAGGCGTGTAAATGAACTAACCTTGCAAGTAAATCAGCTGCAAAATACGGTGGAACGTCATACAAGAAGGCTAAATCGGTTAAATCAACGTCTACGTGTAGTTGAGAATAGGCTGCAAATACCTTTTACTCCTTATGAAGGTGGATTTTAA	MYWYHDPNYVQQYSPDIQQYDYYVYPDLERQPQLFGRVNQLERRVNELTLQVNQLQNTVERHTRRLNRLNQRLRVVENRLQIPFTPYEGGF	MENNKWKQKFFAIYTGQFFSLLSSAAVQFGIIWWLTDKTGGSPLLLTLAGLAGFLPQALVGPFAGTITDRYSRKFLMISADMTVALGSLILFLILHFYEANIIFVILILALRSLATAFHMPAMQASIPLLAPEEALTKVAGWGQMVASVSNIVGPAVGMSILSVSSIKWVLLLDILGAVVASGILLFINIPKIQKTESVELTSFFVEMKEGYNALVNHPILLKLTILMTIVAVLYIPLGTYFPLMTRNHFGKGVVEAGTVEIAFAIGLIVGGSLLGIIGDKFEKVKTMAIGMLLMGLALFFSGLLSPSLFFIFIILSGLVGFSGPLFSAPFYAYIQTEIEPQLLGRIFSFVTSLSLLATPIGYALSGLLIEFTSVSILFSIIGVLVILSGLITLKVK	22.92	gnl|BL_ORD_ID|4754|hsp_num:0	5748			990	1041	
BGC0000795.1|S-layer_38 # 30126 # 30236 # 1 # ID=1_38;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=15bp;gc_cont=0.342	BGC0000795.1|S-layer_38 	30126	30236	+	Loose	200	21.9422	vanX gene in vanP cluster	32.14	3007190	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanX; glycopeptide resistance gene cluster	ATGTACAAAAGAATTGTAAATCTACAGCTTGATGCTCAACGTCCGATAAGCTCTGTTATGCATAATCTGTTATGCATAAAGAGATTATCGGACGTAAGCAAACAAATGTAA	MYKRIVNLQLDAQRPISSVMHNLLCIKRLSDVSKQM	MKSEFVYLDEVIPGVRWDAKYATWDNFMGMPVNGYQVNRVVGTVEMADALKEVSKLAKEKGVGLLLWDGYRPVRAVSHFMEWVKKSKDESRKAKHYPHIDKKTMIEEGYIAEYSGHSRGSTIDLTLYDLESKKLLDMGGDFDLMDEISHYAAEGITKEEKENRKLLRDLMVKCGFVPYENEWWHYSLKDEPYPDTYFDFVIE	17.82	gnl|BL_ORD_ID|4820|hsp_num:0	5806			192	276	vancomycin; teicoplanin
